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Abstract 
For many years scientists considered DNA and RNA to be merely the means for 
the storage and transmission of genetic information. Catalytic roles of some RNA 
molecules, called ribozymes, were discovered in the early 1980s. Considering structural 
similarities between RNA and DNA, it was reasonable to evaluate catalytic competence 
of DNA. Indeed, the first deoxyribozymes were reported in 1994. However, DNA 
enzymes are not found in nature and can only be identified from a pool of random 
sequences via an artificial selection process, referred to as the in vitro selection. DNA 
catalysts capable of supporting various reactivities have been found. 
All deoxyribozymes can be classified as metalloenzymes because they require 
metal ion cofactors, usually at millimolar concentrations. For example, DNA catalysts for 
single-stranded DNA hydrolysis, previously identified in the Silverman laboratory, are 
functional only in presence of Mn2+ and Zn2+ cofactors at millimolar concentrations. 
Chapter 2 describes the discovery via the selection process of two DNA-hydrolyzing 
DNA enzymes that require low micromolar concentrations of a lanthanide ion as the sole 
polyvalent metal ion cofactor. The same selection effort also lead to the identification of 
a number of DNA-hydrolyzing deoxyribozymes that strictly require low micromolar 
lanthanide as well as millimolar Zn2+ concentrations. These DNA catalysts have a range 
of lanthanide dependences, including some deoxyribozymes that strongly favor one 
particular lanthanide ion and others that function well with more than one lanthanide ion. 
In addition to its catalytic competency, DNA is capable of forming strong non-
Watson-Crick binding interactions with various chemical targets, including small 
molecules. DNA sequences possessing this ability are referred to as DNA aptamers and 
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can also be identified via the in vitro selection process. Chapter 3 describes an effort to 
find DNA aptamers of ATP with a further goal of integrating these sequences into 
random DNA pools for deoxyribozyme selection. Providing a fixed binding module 
adjacent to the random region during selection was hypothesized to lead to the emergence 
of DNA sequences tasked exclusively with catalysis. Previously published and well-
studied DNA aptamers of ATP were chosen for this task due to a lack of success in 
identifying new ATP binders.  
Chapter 4 describes selection efforts with an integrated DNA aptamer that lead to 
the identification of a truly modular deoxyribozyme. This DNA enzyme catalyzes 
tyrosine phosphorylation via the transfer of a phosphoryl group from ATP, which must be 
present in solution at concentrations similar to the Kd value of the integrated aptamer. 
Functional contribution of the binding domain to catalysis was confirmed by mutational 
analysis of the aptamer sequence as well as by substitution of ATP target molecules with 
their analogs. 
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Chapter 1: Introduction to Nucleic Acids 
1.1 Importance of Nucleic Acids 
Nucleic acids are essential natural polymeric molecules found in all known forms 
of life. Biopolymers of DNA (deoxyribonucleic acid) or RNA (ribonucleic acid) are used 
for genetic storage, encoding, transmission of hereditary information and even as 
regulatory and catalytic molecules, while monomers are employed in numerous processes 
as cofactors. In academic laboratories around the world these important molecules continue 
to be studied, while nucleic acid-based biotechnologies have become a fundamental part 
of today’s innovative biotechnological and biopharmaceutical industries. 
 
1.2 Chemical Structure and Function of DNA and RNA 
In general, DNA and RNA, the two types of natural macromolecules, are linear 
polymers of nucleotides. In turn, each nucleotide consists of three parts (Fig. 1.1): (i) a 
five-membered pentose sugar ring; (ii) a nucleobase attached to the 1ʹ-carbon of the sugar 
via a glycosidic bond; (iii) a phosphate group, through which the 3ʹ-carbon of one 
nucleotide is connected to the 5ʹ-carbon of its neighbor. Only two structural differences 
exist between DNA and RNA nucleotides: the latter has a hydroxyl group in place of a 
hydrogen at the 2ʹ-position of the sugar and uses a uracil (U) nucleobase instead of thymine 
(T). Both polymers have adenine (A), guanine (G) and cytosine (C) as bases. The 
complementarity of nucleic acid polymers arises from hydrogen-bond interactions between 
A and T (or U) as well as G and C nucleobases referred to as Watson-Crick base-pairing. 
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1.2.1 DNA chemical structure and function 
DNA in nature is mostly found in a right-handed double-helical form with two 
DNA strands coiled along the same axis but running in anti-parallel directions; each strand 
has a pitch of 3.4 nm and a radius of 1.0 nm.1 There are about 10 nucleotides per full turn 
of the helix. Two space voids, referred to as grooves, run parallel to the DNA strands. 
Because the strands are not symmetric with respect to each other, the grooves have different 
sizes with the major groove 2.2 nm wide and the minor groove 1.2 nm wide.2 Although 
hydrogen bonds between complementary nucleobases are important for stability, the major 
forces defining this structure come from the  stacking interactions between highly 
conjugated purine and pyrimidine rings separated by 0.34 nm. It has been estimated that 
stacking alone can contribute up to –1.0 kcal/mol per each stacking interaction while base-
pairing adds a maximum of –0.8 kcal/mol per base pair.3 
Figure 1.1: A single monomer of DNA or RNA and the five natural nucleobases. 
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The Nobel Prize in Physiology or Medicine was awarded to Crick and Watson for 
their X-ray studies of the DNA structure first published in 1953.4 The described double-
helical form of DNA, also known as the B-form, is its most common composition in living 
cells. However, other double-helical forms of complementary DNA:DNA, DNA:RNA and 
RNA:RNA strands are known. One of them, known as the Z form, has a left-handed helical 
twist.5 Structures containing three and four DNA strands have also been characterized.6 
Observation of the alternate structures depends on hydration levels, identity and 
concentration of metal ions, pH and nucleobase make-up, among other factors. 
Genes, units of hereditary information of life, are segments of DNA which encode 
RNA molecules as well as protein sequences, another type of essential macromolecule of 
life. As such, genes hold the necessary information to build and maintain cells and pass 
traits of an organism to its offspring. Genes can be as short as 76 nucleotides and as long 
as 2.2 million nucleotides and are located in chromosomes, structures of highly coiled DNA 
found inside nuclei of eukaryotic cells and in the cytoplasm of prokaryotes.7  
 
1.2.2 RNA chemical structure and function 
An important intermediate between DNA in a gene and a protein encoded by that 
gene is mRNA (messenger RNA). While DNA commonly occurs in nature in a double-
helical form, it is typical of RNA to be single-stranded. Although lacking a separate 
complementary strand, RNA is capable of forming intrastrand hydrogen bonding between 
stretches of complementary nucleotides, thus folding into complex, three-dimensional 
structures. 
4 
 
RNA molecules are separated into several categories, based on their function inside 
a cell. Previously mentioned mRNA serves as an intermediate template for protein 
synthesis.8 mRNA is constructed by RNA polymerase via complementary base-pairing 
from a DNA template located on the antisense strand of a double helix in a process referred 
to as transcription. mRNA is synthesized in a 5ʹ to 3ʹ direction while the DNA strand is 
read in the opposite, 3ʹ to 5ʹ direction. After transcription, mRNA molecules must be 
processed: noncoding regions are removed during mRNA splicing, the 5ʹ ends are capped 
with 7-methylguanosine and a long polyA tails are added to the 3ʹ end to protect the 
molecule from degradation.9 In mRNA, each set of three consecutive nucleotides is called 
a codon. Four nucleotide identities and three positions in a codon provide for a total of 64 
unique codons. Each codon encodes a single natural amino acid with the notable exception 
of three stop codons each of which terminates protein synthesis. There is a degeneracy of 
the genetic code as 61 remaining codons specify 20 amino acids; in most cases, codons for 
the same amino acid differ only in their third position. The information encoded in mRNA 
is used to build proteins in a process known as translation where the identity of the amino 
acid to be installed is based on nucleotide base-pairing between sequences of the codon 
from mRNA and the anticodon in transfer RNA, or tRNA, another type of natural RNA 
molecule. These highly structured adaptor molecules are encoded by DNA in what is 
considered to be the set of shortest genes. Single amino acids are attached to the 3ʹ end of 
a tRNA molecule. Nucleobase modifications are common throughout a tRNA sequence 
and most often include methylation. Sometimes the first anticodon nucleotide, also known 
as a wobble base that is able to base-pair to more than one nucleobase of the codon, is 
modified to pseudouridine (from U), inosine (from A) or lysidine (from C).10 The third 
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most common functional RNA is the ribosomal RNA, or rRNA. Together with structurally 
required proteins, rRNA makes up the ribosome, the catalyst of the translation process. 
Ribosome structures vary for prokaryotes and eukaryotes but all can be generalized to 
having two domains: one large and one small subunit. One eukryotic ribosome is made up 
of four RNA sequences containing a total of 7216 nucleotides, while that of E. coli has 
three strands and is 4568 bases long.11 The differences between human and bacterial 
ribosomes are sufficient enough for specific targeting of the latter by some antibiotics 
without significant side effects.12 
 
1.3 Other Functional RNA Molecules 
In addition to RNA molecules that participate in transcriptional and translational 
processes of gene expression, other functional molecules of this biopolymer are present in 
organisms. Below are brief descriptions of several such examples: riboswitches, small 
interfering RNAs and ribozymes. 
 
1.3.1 Riboswitches 
 In addition to more complicated mechanisms involving macromolecules, small 
molecules (especially metabolites) can regulate expression of genes which typically code 
for proteins involved in transport or biogenesis of these metabolites.13,14 The small 
molecule targets bind directly to a non-coding regulatory region at the 5ʹ end of mRNA 
known as the riboswitch segment. Although they are parts of mRNA molecules, 
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riboswitches can be discussed separately from simple mRNA due to their unique 
properties. Even very similar molecular analogs of the small molecule target are 
discriminated against by riboswitches. This very specific interaction results in a structural 
change of the sequence due to the presence of regions capable of alternative base-paring 
near the small molecule binding sites (Fig. 1.2) and regulates expression of a protein it 
encodes. Most riboswitches downregulate gene expression upon binding of the small-
molecule metabolite while a fewer number of these RNAs can turn it on. The evolutionarily 
conserved segment with such great specificity of binding is called the aptamer region of 
the riboswitch. The existence of this regulatory mechanism had been postulated in the 
1960’s but the fact that mRNA can bind metabolites was first shown in 2002 in Ronald 
Breaker’s laboratory at Yale.15 Prior to that, in 1998, Tina Henkin and coworkers from the 
Ohio State University first observed this gene regulatory pathway.16 Interestingly, these 
naturally occurring polynucleotide binders were found more than a decade after artificial 
DNA and RNA aptamers were identified.17,18 Currently known riboswitches can sense 
various molecules including purines, protein coenzymes, amino acids, metal ions and even 
negatively charged fluoride ions.19 Most notable examples of riboswitch regulatory 
mechanisms involve formation of mutually exclusive conformations of RNA that affect 
either transcription or translation processes in bacteria. Intrinsic terminator or 
antiterminator stem-loops are created to inhibit or to activate transcription, respectively. In 
a similar manner, translation is regulated by the sequestration or release of ribosome-
binding sites on mRNA. In eukaryotes, riboswitches regulate gene expression via 
alternative splicing, which is a mechanism in which exon regions are rejoined in various 
combinations after removal of introns to produce different mRNA sequences.13 Binding of 
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a target molecule by the riboswitch exposes previously hidden splice site. This binding-
induced splicing event then leads to either premature termination of the translation process 
or production of a non-functional polypeptide. The topic of riboswitches is currently very 
prominent in the field of nucleic acids research as scientists explore the potential for these 
RNA sequences in applications for medicine and biotechnology.13 
 
Figure 1.2: Schematic bar (upper panels) and structural (lower panels) representations of 
three common junctional folds in riboswitches: “straight” (A) with thiamine pyrophosphate, 
“inverse” (B) with tetrahydrofolate and “pseudoknot” (C) with a fluoride ion. Magenta-
colored P1 regions are capable of alternate base-pairing; 3WJ is a three-way junction; pink 
and blue-shaded areas represent ligand-binding sites and long-distance tertiary 
interactions, respectively. Adopted from reference 13 with permission. 
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1.3.2 siRNA and RNA interference 
 Gene expression can also be regulated by small interfering RNA, or siRNA, which 
is another type of RNA. These are complementary double-stranded RNA sequences of ~20 
base pairs with two-nucleotide overhangs at 3ʹ-OH ends and phosphorylated 5ʹ-termini. 
siRNA production is catalyzed by the Dicer enzyme from a longer double-stranded 
construct which is expressed inside the cell or can be introduced there (e.g., by 
transfection).20,21 One of the strands, referred to as the guide strand, can base-pair with a 
complementary region of mRNA and lead to its degradation in a process referred to as 
RNA interference, or RNAi, which follows a sequence of events. First, to separate the two 
strands of siRNA from each other, the duplex is bound to the RISC (RNA-Induced 
Silencing Complex) protein complex which promotes its unwinding while endonucleases 
degrade the unbound siRNA strand. The guide strand thus becomes free to base-pair to its 
target mRNA inside the cell. Upon base-pairing, the RISC complex catalyzes ATP-
dependent cleavage of mRNA, preventing expression of the protein encoded by that 
sequence, i.e. silencing a particular gene.22 Because siRNA targeting is based solely on its 
complementarity to an mRNA sequence, theoretically any gene can be knocked down 
through this approach as long as the corresponding mRNA sequence is known. Discovery 
of RNA interference holds a lot of promise for science and technology and was recognized 
with the 2006 Nobel Prize in Physiology or Medicine only eight years after publication of 
results which unequivocally tied the gene silencing observation to introduction of double-
stranded RNA into cells.23 RNAi technology is a “hot” topic today in academia and 
industry alike: antiviral and cancer treatments, food and agricultural technology 
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applications as well as numerous other medical and biotechnology uses for RNAi are being 
developed in the laboratories around the world.24 
 
1.3.3 Ribozymes 
Ever since the catalytic role of proteins was discovered and the central dogma of 
molecular biology was formulated, both nucleic acid polymers, DNA and RNA, were 
considered nature’s tools exclusively for storage and transmittal of genetic information or, 
more specifically, as templates that encode proteins.25 This principle was put into question 
by observations of complex secondary and tertiary structure formation by RNA and 
dismissed after the discoveries of self-cleaving introns and of tRNA-forming protein-RNA 
complexes in which the RNA component (in some cases with only structural assistance 
from proteins) was responsible for the catalytic steps. Just as the case with protein enzymes, 
ribozymes require rigorous geometrical positioning of the catalytic site with respect to the 
substrate of the reaction. For example, one of the first ribozymes identified was a self-
splicing Group I intron from Tetrahymena thermophila which sequentially acts on two 
phosphodiester bonds via SN2 transesterification mechanisms.
26 In the first of two 
reactions, a specifically bound and required exogenous guanosine substrate is used to free 
the 5ʹ exon, leaving a hydroxyl group at its 3ʹ-terminus (Fig. 1.3). This 3ʹ-OH then serves 
as the nucleophile to attack precisely at the phosphodiester bond separating the intron 
sequence from the 3ʹ exon of mRNA, rejoining the latter to the 5ʹ exon and completing the 
splicing process. This fine-tuned excision mechanism requires perfect positioning of the 
substrates in the catalytic site which in turn must be accurately folded. Just like protein 
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enzymes, ribozymes adopt stable and well-defined secondary and tertiary structures that 
can be elucidated by X-ray crystallography.27 
 
For his discovery and description of the self-splicing ribozyme, Dr. Thomas Cech 
was awarded the 1989 Nobel Prize in Chemistry. He shared this award with Dr. Sidney 
Altman who at around the same time found another catalytic RNA sequence that is an 
essential part of the RNAse P complex responsible for removing a 5ʹ-leader region from 
pre-tRNA.28 The ribozyme discovered by Dr. Altman became one of few examples of 
natural RNA catalysts capable of multiple turnover, in addition to the Group I intron and 
the ribosome. RNAse P catalyzes phosphodiester bond hydrolysis to produce mature tRNA 
molecules and, with some sequence variations, may be found in all living organisms 
capable of the protein translation process for which tRNA is required. 
As mentioned in section 1.2.2, rRNA makes up the ribosome, the most widely 
known example of a natural ribozyme, which is the sole catalyst of peptide bond 
formation.29 The sequence of rRNA in the active site is conserved in all eukaryotes, 
Figure 1.3: Catalytic mechanism of Group I intron for the first of two sequential 
reactions. Exogenous guanosine is shown in green, last nucleotide of the 
5ʹ exon is blue and the first nucleotide of the intron is red. 
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indicating the utmost importance of the translation process to life.30 Briefly, during 
translation, an aminoacyl-tRNA molecule carrying its cognate amino acid bound to the 3ʹ 
terminal hydroxyl enters the A site of the ribosome. This amino acid is added to the 
growing polypeptide chain’s carboxyl end, forming peptidyl-tRNA (Fig. 1.4). After 
transferring the elongating protein to the next adapter molecule, this uncharged tRNA exits 
the ribosome at the E site. Although 56 different proteins (in E. coli) are required for the 
ribosome’s structural stability, the entire complicated process of translation is orchestrated 
by the active site’s perfectly-positioned rRNA nucleotides, which have remained 
conserved through billions of years of evolution on Earth. 
 
Lacking protein’s versatile functional groups, naturally occurring catalytic RNA 
molecules under physiological conditions require divalent metal ions (most commonly 
Mg2+) as cofactors for their activity.31 Metal ions stabilize catalytically active 
conformations, activate functional groups and participate in the acid-base chemistry of 
ribozymes. Since high sensitivity of these catalysts to the concentration and identity of 
Figure 1.4: Peptide bond formation catalyzed by rRNA in the P site of the ribosome. The new 
amino acid (red) becomes attached to the already synthesized polymer (blue).  
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metal ions was experimentally demonstrated, most ribozymes should be placed in the class 
of metalloenzymes. 
After the discoveries of previously unfathomable RNA functionalities in the recent 
decades, some members of the scientific community began to suggest that early life on 
Earth was RNA-based in what is widely known as the “RNA World hypothesis”.32-35 In 
addition to the various catalytic and binding abilities of RNA polymers, nucleotides and 
their derivatives such as ATP, NADH, acetyl-CoA and others serve as obligatory cofactors 
for most essential biological processes. The RNA World hypothesis postulates that proteins 
as the cell’s main catalysts emerged later during the development of life on Earth and may 
have since replaced many functional RNA molecules. This idea suggested that although 
not present in living organisms, additional RNA catalysts and binders can be identified in 
the laboratory. 
 
1.4 Non-natural Functional Nucleic Acids 
 Natural selection is a gradual and often very slow process by which desirable traits 
become more common in a population with each new generation. At the very basis of 
natural selection are genes, the units of hereditary information, composed of nucleotides. 
The process of replication is not perfect and errors, known as mutations, can be made when 
genes are copied. While most mutations tend to lower an organism’s fitness, some may be 
advantageous. Importantly, without serendipitous errors during copying of genetic 
information, there would be no chance to improve traits in a population as its old 
generations are replaced by the new ones through time. Although fascinating because of 
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its power to advance fitness, the opportunistic process of natural selection is not suitable 
for a typical biochemical laboratory that aims to evolve a functional nucleic acid on a 
reasonable time scale. Instead, scientists prefer to start with large populations in which 
each member is different from every other because a high number of unique members 
present increases the chance of finding at least one with the ability to perform the desired 
function. This method of identifying functional molecules in a laboratory is known as in 
vitro selection and is generally used for RNA and DNA as it is impossible to be applied to 
amino acid polymers for several reasons.17 First, due to higher sequence space coverage, a 
nucleic acid polymer of a given length (e. g., 40 monomers) can have 440 ≈ 1024 possible 
unique sequences. The number of unique polypeptides of this length is 2040 ≈ 1052. Because 
it is not feasible to make all possible sequence variants for either polymer, the lower 
number of natural poly(ribo)nucleotide building blocks means that a greater fraction of 
nucleic acid polymers than polypeptides can be searched. Importantly, direct length 
comparison is not accurate. Natural functional proteins (on average) are made up of more 
monomer building blocks than functional single-stranded nucleic acids. The need for 
testing longer polymers further reduces sequence coverage of polypeptides. Second, 
random sequences of single-stranded nucleic acids of appreciable length tend to inherently 
adopt secondary as well as tertiary structures with intricate folds and interactions, the basis 
of functionality. Polypeptides, on the other hand, require numerous constant stretches of 
amino acids to support proper protein folding. Building in these conserved regions and 
preserving their fidelity is not compatible with the in vitro selection approach. 
In addition to the conceptual reasons outlined above, there are practical advantages 
in using nucleic acids over polypeptides. Production of polynucleotides is easier in terms 
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of cost and time, relative to bacterial expression of proteins. Single-stranded nucleic acid 
polymers can be prepared via solid-phase synthesis on automated synthesizers. By using a 
mixture of the four natural nucleotide derivatives, typically in equal proportions, as many 
as 1016 (~20 nmol) unique random sequences can be synthesized in the same vessel and 
purified together. The total length of each individual sequence is exactly the same while 
masses differ only slightly. The entirety of all members of this sequence library is referred 
to as the pool. Flanking the random sequence regions, two constant nucleic acid sections 
of known identity (each typically 15-20 nucleotides in length) must be present in each 
member of the pool for amplification purposes. After separating them from non-functional 
sequences, polymers with desired properties must be amplified in order to increase the total 
number of each of these unique sequences via polymerase chain reaction (PCR), a 
technique without which the in vitro selection process would not be viable. In PCR, a 
complementary sequence binds to the 3ʹ constant region of each pool member present to 
serve as a template for a thermostable polymerase enzyme that performs the synthesis of 
the exact complement of the random region as well as the 5ʹ conserved region.36 In the next 
cycle of PCR, the second template sequence binds to the 3ʹ end of the reverse complement 
followed by the polymerase-catalyzed synthesis of the exact copy of the functional nucleic 
acid polymer. Repetition of these steps during multiple cycles of PCR provides exponential 
amplification of desired sequences. In addition to their role in template binding for PCR, 
conserved regions of the pool are used as attachment points for various nucleic acid-
conjugated substrates via complementary Watson-Crick base-pairing to each member of 
the sequence library. Separation of functional sequences from the non-functional ones will 
be further discussed in Chapter 2, but it is generally performed using polyacrylamide gel 
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electrophoresis for catalyst selections and via specific binding to molecular targets on a 
solid support for aptamer identification. 
 
1.4.1 RNA and DNA aptamers 
Nucleic acid aptamers are polymers of defined sequences that bind to their specific 
target molecules. As discussed earlier, riboswitches have aptamer segments which were 
evolved naturally. Interestingly, the first known aptamers were not found in nature. They 
were identified prior to the discovery of riboswitches by two separate laboratories via 
artificial evolution, or in vitro selection, more than a decade earlier.17,18 More specifically, 
the process of identifying nucleic acid binders is known as SELEX (Systematic Evolution 
of Ligands by Exponential Enrichment). In this method, unique single-stranded RNA or 
DNA sequences with an affinity to a specific molecule are selected out of a random pool 
by binding their molecular targets appended to a solid support (e.g., an agarose bead).18 An 
additional description of aptamer selection process with specific examples is given in 
Chapter 3 of this thesis. 
 
1.4.2 Artificial ribozymes 
After natural catalytic single-stranded RNAs were discovered, scientists became 
determined to identify unnatural ribozymes. This task necessitated establishing a method 
of separating a small minority of catalytically active sequences from the rest. For example, 
in some of the first selections aimed to identify RNA-cleaving and RNA-ligating 
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ribozymes, the catalytic sequences either acquired or lost a tag, such as a biotin or a thiol 
functional group, allowing for separating these from the rest.37 Gel shift also provides 
separation since the total length of the active sequences changed due to catalytic activity.38 
Because RNA cannot be directly amplified, two additional steps are required for 
regeneration of the sequence pool. After the separation steps, RNA sequences must be 
reverse-transcribed into complementary DNA. Following the subsequent PCR step, the 
now-amplified reverse complement DNA pool must be transcribed into RNA, and this 
newly regenerated pool is ready to undergo the next round of selection to further enrich the 
ratio of catalytically active RNA molecules to inactive ones.39 After sequences with desired 
activities have emerged from the pool and began dominating it, their identities can be 
resolved after cloning, testing individual clones for catalytic activity and sequencing the 
best candidates. Again, due to the presence of an identical conserved region in each 
molecule of the pool, each clone can be transcribed using a template that is complementary 
to the constant portion without regard to the composition of the random region. Each 
transcribed RNA molecule is then presented with a substrate, and the reaction is performed 
under the conditions used during in vitro selection in a process called screening. DNA 
clones of RNA sequences capable of catalyzing the reaction of interest above a chosen 
threshold are then sequenced. The sequences are aligned to find areas of conservation, 
which may provide hints of the catalytic region’s location. Finally, individual ribozymes 
are prepared for comprehensive studies of catalysis. 
The scope of reactions catalyzed by artificial ribozymes is not limited to RNA 
ligation and cleavage. Catalytic RNA molecules capable of numerous other reactivities 
have been identified in various laboratories by in vitro selection experiments and this 
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process continues today.40-42 Table 1.1 provides several examples of a wide range of 
reactivities catalyzed by ribozymes identified via the in vitro selection process. 
Ribozyme-catalyzed … Reference Ribozyme-catalyzed … Refererence 
RNA cleavage 38 Nucleotide synthesis (Fig. 1.5) 43 
RNA ligation 44 Amide synthesis (Fig. 1.5) 45 
RNA phosphorylation 46 N7G alkylation 37 
RNA capping 47 Aminoacylation 48 
RNA branching 49 Michael reaction 50 
RNA-protein conjugation 51 Porphyrin metalation 52 
Diels-Alder reaction 53 Biphenyl isomerization 54 
Table 1.1: Non-comprehensive list of ribozyme-catalyzed reactions and references to 
reports. Adapted from reference 39. 
 
1.4.3 Deoxyribozymes 
 Even though ribozymes both exist in nature and can be identified in the laboratory, 
deoxyribozymes (also referred to as DNA enzymes or DNA catalysts), single-stranded 
catalytic DNA molecules, have not been found in living organisms.55 However, the first 
Figure 1.5: Reactions catalyzed by artificial deoxyribozymes: pyrimidine nucleotide 
synthesis (A) and amide synthesis (B). 
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DNA catalyst obtained via in vitro selection was reported in 1994.56 The two nucleic acid 
biopolymers are very similar: DNA lacks the 2ʹ-OH and has the thymine nucleobase in 
place of uracil (a difference of a single methyl group). The use of DNA has additional 
advantages over RNA:  
i) Greater stability since self-cleavage is not possible without 2ʹ-OH of RNA; 
ii) DNA is directly amplifiable without the need for transcription and reverse 
transcription steps during each round of in vitro selection; 
iii) Simplicity and cost advantages of DNA solid-phase synthesis versus RNA. 
To find deoxyribozymes, scientists employ the same in vitro selection methodology as with 
ribozymes, but without transcription and reverse transcription steps in each round. The 
earliest DNA catalyst to be identified, Pb2+-dependent deoxyribozyme, catalyzes the 
cleavage of the phosphodiester bond at a single ribonucleotide linkage flanked by an 
all-DNA substrate sequence (Fig. 1.6). For its activity this DNA enzyme strictly requires 
Pb2+ as a divalent metal ion cofactor and displays a rate enhancement of 105 over the 
uncatalyzed background reaction under comparable conditions. Discovery of the Pb2+-
dependent DNA catalyst was followed by identification of numerous additional RNA-
cleaving deoxyribozymes generally separated into two classes: variants of the 10-23 and 
8-27 family of DNA enzymes. The diversity of reactions catalyzed by deoxyribozymes is 
continuing to expand and a few examples are given in Table 1.2. 
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Deoxyribozyme-catalyzed … Reference Deoxyribozyme-catalyzed … Reference 
RNA cleavage 56 Phosphoramidate cleavage 57 
RNA ligation 58 Phosphoramidate linkage 59 
RNA branching 60 Oxidative DNA cleavage 61 
RNA lariat formation 62 DNA hydrolysis 63 
RNA hydrolysis 64 Reductive amination 65 
DNA phosphorylation  66 Ester bond hydrolysis 67 
DNA adenylylation 68 Aromatic amide bond hydrolysis 67 
DNA ligation 69a Lysine side chain modification 69b 
DNA deglycosylation 70 Tyrosine dephosphorylation 71 
Thymine dimer photoreveral 72 Tyrosine phosphorylation 73 
Table 1.2: Non-comprehensive list of deoxyribozyme-catalyzed reactions and references to 
reports. Partially adapted from reference 39. 
 
Currently, DNA catalysts for RNA cleavage find the most therapeutic utility 
potential.74 This is partially due to the fact that these type of DNA enzymes were some of 
the first to be identified and partially due to rapid development of RNAi technologies with 
a similar RNA phosphodiester bond breakage leading to gene silencing. Advantageously, 
deoxyribozymes do not require additional catalytic functional components such as RISC 
for siRNA. Additional benefits of using catalytic DNA instead of RNA enzymes include 
Figure 1.6: Representation of the 
10-23 deoxyribozyme complex with 
its substrate. The substrate contains 
a single adenosine ribonucleotide 
(blue) flanked by the all-DNA 
sequence (teal). Catalytic region of 
DNA enzyme (green) is flanked by 
binding arms (brown). Arrow points 
at the phosphodiester bond cleaved 
by the 10-23 deoxyribozyme. 
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their greater target specificity and lower costs associated with its synthesis.75 
Unfortunately, the current absence of efficient nucleic acid delivery agents is delaying the 
therapeutic development of deoxyribozymes as well as other antisense technologies. As a 
result, no clinical trials of RNA-cleaving deoxyribozymes have been reported yet.74 
 
1.5 Protein Side Chain Phosphorylation 
 Proteins are long functional biological polymers consisting of amino acid building 
blocks. Most organisms have 20 amino acid monomers encoded by the universal genetic 
code and connected by peptide bonds. Protein functions are determined by their three-
dimensional structures adopted on the basis of amino acid sequence. Structure and function 
of most proteins can be altered by posttranslational modifications (PTMs), covalent 
attachment of chemical groups to the side chains of some amino acids.76 Generally, 
posttranslational modifications are catalyzed by specific proteins. An example of a PTM is 
linkage of a phosphate to nucleophilic residues of tyrosine, serine, threonine and histidine 
where an exogenous ATP or GTP nucleotide serves as the phosphoryl donor.77 
Posttranslational phosphorylation is catalyzed by protein kinases while phosphatases 
catalyze dephosphorylation. These modifications serve as an important regulatory 
mechanism by which proteins are either activated or turned off due to resulting structural 
change. For example, phosphorylation of tyrosine in transmembrane receptor proteins turns 
on a host of cellular signaling pathways, including those that control translation, 
transcription, cell cycle progression, and vesicle transport, as well as cytoskeletal and 
calcium signaling.78 To study the plethora of cell-regulating interactions, scientists require 
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innovative approaches to phosphorylate specific amino acid side chains of proteins 
involved in these events. 
 
1.6 Lanthanide Ions 
 Collectively known as rare earth elements, the lanthanide series contains fifteen 
metallic chemical elements from lanthanum (atomic number 57) to lutetium (atomic 
number 71) and is characterized by filling of the 4f electron shell. Chemical and physical 
properties of lanthanides are very similar to each other with the most stable oxidation state 
of 3+, although several of the elements are known to also form stable 2+ and 4+ ions.79 
The main difference arises from filling the f orbital and is referred to as the lanthanide 
contraction phenomenon, where the radii of ions with the 3+ oxidation state decrease from 
103 pm for La3+ to 86 pm for Lu3+. All lanthanide ions form coordination complexes with 
a range of coordination numbers and geometries. Due to their high positive charges, 
lanthanides act as good Lewis acids and are also known to bind tightly to nucleic acids.80 
Rare earths are becoming a more expensive commodity as they find wider usage in many 
modern products such as cell phone and hybrid vehicle batteries, magnets, lasers, catalytic 
converters, catalysts for fuel refining and in glass production as well as in numerous other 
industrial applications. Due to their unique fluorescent properties, Eu3+ and Tb3+ ion 
complexes are used in biological sciences in FRET (fluorescence resonance energy 
transfer) assays to study interactions on a molecular level.81 Until recently, lanthanides 
have not been found to be used in natural biological processes. However, in 2014, Ce3+ 
ions were reported to be essential for energy production by the Methylacidiphilum 
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fumariolicum SolV bacterium.82 Usually filled by a calcium ion, the active site of the 
methanol dehydrogenase enzyme of this species is too large for calcium but provides a 
perfect fit for a cerium ion. 
 
1.7 Research Focus of This Thesis 
 The research reported in this thesis was aimed at identification of deoxyribozymes 
with novel cofactor and module requirements. To facilitate the discovery of these nucleic 
acid enzymes, reactivities already known to be catalyzed by DNA were chosen. Sequence-
dependent hydrolysis of phosphodiester bonds in single-stranded DNA by 
deoxyribozymes63 and DNA catalysts with tyrosine kinase activity73 have been reported by 
other Silverman lab members, and here these reactivities were probed under novel in vitro 
selection conditions. All new DNA enzymes described in this thesis were identified from 
unbiased random sequence pools. 
 In Chapter 2, the ability of Ce3+, Eu3+ and Yb3+ at low micromolar concentrations 
to serve as metal ion cofactors in facilitating the discovery of deoxyribozymes was 
evaluated in the context of DNA cleavage. Attempts at identifying DNA aptamers for small 
molecules are discussed in Chapter 3. Finally, Chapter 4 is focused on evaluating the utility 
of incorporating DNA aptamer modules into random sequence pools as binding sites for 
ATP substrates of tyrosine phosphorylation reactions. 
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Chapter 2: Exploration of Requirements of Metal Ions as Cofactors for 
DNA Catalystsa 
2.1 Introduction 
 Deoxyribozymes generally require one or more divalent metal ions as cofactors. 
Typical metal ion cofactors are Mg2+, Ca2+, Mn2+ and Zn2+.1 In previous work, other 
members of the laboratory have performed selection experiments with Mn2+ together with 
at least one other divalent metal ion cofactor. Some of these experiments led to successful 
identification of DNA enzymes that catalyze hydrolysis of phosphodiester bonds in single-
stranded DNA.2-5 For example, 10MD5, the best initial DNA-hydrolyzing deoxyribozyme, 
requires Zn2+ and Mn2+ for its catalytic activity and was selected with Mg2+ in addition to 
the two obligatory metal ions. However, via reselection experiments based on partial 
randomization of the 10MD5 sequence and follow-up studies, a 10MD5 mutant that 
requires only Zn2+ for is activity was identified.4 Because Mn2+ is redox-active and DNA 
is sensitive to oxidative degradation,6-9 we wanted to identify new deoxyribozymes that do 
not require Mn2+ for their hydrolytic function. Toward this goal, we decided to evaluate 
the ability to identify entirely new (starting from a completely random pool) DNA-
hydrolyzing deoxyribozymes by selection using Zn2+ alone or in combination with Mg2+ 
or Ca2+ ions. In a separate experiment, the presence of Mn2+ as a single polyvalent metal 
ion cofactor was also evaluated. 
                                                          
a The material described in this chapter has been published and is used here with permission: 
Dokukin, V.; Silverman S. K., Lanthanide ions as required cofactors for DNA Catalysts. Chem. 
Sci. 2012, 3, 1707-1714. 
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 In a parallel effort, we evaluated the ability of trivalent lanthanide ions at low 
micromolar concentrations to support DNA-catalyzed cleavage of DNA. In preliminary 
work, we attempted to explore the usefulness of these metal ions with existing DNA 
catalysts. Either Zn2+ or Mn2+, initially believed to be required for a new DNA-hydrolyzing 
deoxyribozyme, was substituted with one of seven different trivalent lanthanide ions in the 
reaction mixture. In later work for practical reasons, only three lanthanides, Ce3+, Eu3+ and 
Yb3+, were chosen for selection experiments. Due to significant differences in their ionic 
radii (Ce3+ 102 pm, Eu3+ 95 pm, Yb3+ 86 pm in hexacoordinate environments), these ions 
could represent early, middle and late regions of the lanthanide row, respectively (Fig. 2.1). 
The luminescent properties of Eu3+ (also Tb3+) are widely known and both lanthanide ions 
have been used as structural and mechanistic probes for nucleic acids.10 Identification of 
new Eu3+-dependent deoxyribozymes could therefore simplify biochemical 
characterization of catalysts found in these studies or any other future DNA enzymes with 
remarkable properties selected with and requiring the presence of these luminescent metal 
ions. 
 
 
 
Figure 2.1: Lanthanide row of the periodic table. 
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2.2 Results and Discussion 
2.2.1 Evaluating a known deoxyribozyme’s activity with lanthanide ions 
 Encouraged by tight binding interactions that these metal ions form with nucleic 
acids and with knowledge that lanthanides have been reported as alternative catalytic 
cofactors for a particular RNA-cleaving DNA enzyme originally identified to require 
Pb2+,11 we first decided to test a recently identified deoxyribozyme. 9NL27 is a quintuple 
mutant of 10MD5 (the first-ever DNA catalyst of single-stranded DNA hydrolysis), 
reselected from a partially randomized pool for the purpose of expanding the pH range of 
these deoxyribozymes.3 Just like 10MD5, the catalysis by 9NL27 was initially observed to 
require both Zn2+ (1 mM optimum) and Mn2+ (Kd,app ~ 5 mM). A lanthanide ion’s ability 
to substitute for Zn2+ or Mn2+ (or both ions) in supporting 9NL27 catalysis was initially 
tested with seven different elements in the 3+ oxidation state (Ce, Eu, Gd, Tb, Dy, Yb and 
Lu), each at 5 M, 100 M and 2 mM. In the case when Mn2+ was substituted, all trivalent 
ions at 2 mM concentrations inhibited the catalysis by 9NL27, while at lower 
concentrations, DNA hydrolysis activity was observed at a rate comparable to that with 
both original divalent metal ions. Substitution of a lanthanide cofactor for either Zn2+ or 
both divalent metal ions did not support detectable product formation (Fig. 2.2). This led 
us to the hypothesis that 20 mM Mn2+ can be substituted with a lanthanide ion at a 
significantly lower concentration. To find the Kd values for lanthanide cofactors, a series 
of Ce3+, Eu3+ and Yb3+ concentration ranges were tested. Surprisingly, even at nanomolar 
concentrations, significant 9NL27 catalysis was observed, raising doubts regarding 
catalytic roles of lanthanides as cofactors. A negative control experiment with Zn2+ alone 
(without both Mn2+ and Ln3+) was performed, revealing the monometallic requirement of 
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9NL27 catalysis (Fig. 2.2). This observation resulted in significant advances in 
understanding the characteristics of single-stranded DNA hydrolysis by DNA enzymes by 
other members of the laboratory.4 
 
2.2.2 Early selection experiments with trivalent lanthanide (Ce3+, Eu3+, 
Yb3+) and divalent metal ions (Zn2+, Mn2+, Mg2+, Ca2+) 
 Inspired by natural selection, the combinatorial technique of in vitro selection is 
designed to identify DNA enzymes with novel catalytic properties. Selection of DNA 
catalysts (e.g., for single-stranded DNA hydrolysis) using this approach involves the 
following steps (Fig. 2.3). A pool of DNA sequences, each consisting of a random region 
of the same length (e.g., 40 nucleotides) flanked by constant regions, is generated via solid-
phase synthesis. The constant regions are used to bind primers which serve as templates 
for PCR amplification and for binding of substrate, consisting of primarily complementary 
DNA sequence and a ribonucleotide GGA segment at the 3ʹ end. One substrate sequence 
is then covalently attached to each molecule of DNA pool via reaction catalyzed by the 
RNA ligase enzyme. In the next step, referred to as the selection step, catalytically active 
DNA sequences lead to shorter deoxyribozyme-product conjugates that migrate more 
Figure 2.2: PAGE assays of 9NL27 metal ion requirements with 10 M each Ce3+, Eu3+ or Yb3+ 
substituting either one or both of Zn2+ (1 mM) and Mn2+ (20 mM). Negative control assay with 
1 mM Zn2+ alone. Timepoints at t = 1 h, 18 h.  
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quickly on PAGE. Each selection step is performed in the presence of cofactors such as 
lanthanides as well as other metal ions and a buffer of certain pH. Separation methods 
depend upon the reactions being catalyzed. In this example, cleavage of the single-stranded 
DNA substrate anywhere within its central region yields molecules with lower mass and 
total negative charge, which (due to their faster electrophoretic mobility) are easily 
separated on PAGE from sequences with uncleaved substrates. The sequences extracted 
from the gel are then amplified by PCR, followed by ligation and selection steps. These 
cycles are repeated for several rounds, enriching catalytic sequences iteratively with every 
round. When catalytic activity of a pool levels off, the individual members of the pool are 
cloned, sequenced and assayed. Characterization assays are performed intermolecularly, 
i.e., without covalent attachment of the pool sequences to the substrate (indicated by the 
orange arrow in Fig. 2.3), in order to find general catalysts because potential DNA cleavage 
applications would only be useful without the deoxyribozyme-substrate conjugation. 
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To test viability of lanthanide ions as catalytic cofactors for de novo identification 
of DNA catalysts, a selection experiment, arbitrarily designated SA (according to our 
laboratory’s systematic nomenclature), with a mixture of 1 M each Ce3+, Eu3+ and Yb3+ 
was performed. Because single-stranded DNA cleavage by deoxyribozymes was recently 
achieved2 and the methods of selection and further characterization of catalysts already 
established,3 this reactivity was chosen for the new study. In addition to the selection with 
the three lanthanides alone, selection experiments with one of 1 mM Zn2+ (SB), 10 mM 
Mg2+ (SC) or 10 mM Ca2+ (SD) together with 1 M lanthanides were performed. For each 
selection, the key incubation step was performed for 12 h in the presence of either 50 mM 
(SA, SC, SD) or 70 mM (SB) HEPES, pH 7.5 and 150 mM NaCl at 37°C. Unlike the 
remainder of the metal ions used here, the 10 × Zn2+ stock was prepared in 200 mM 
Figure 2.3: In vitro selection strategy to identify deoxyribozymes that cleave DNA. Substrate 
sequence (blue) with one unpaired C nucleotide is Watson-Crick base-paired to the pool’s 
constant regions (brown) flanking the random region (green). The forward primer (pink) 
templates synthesis of the pool’s sequences during PCR from their reverse complements 
templated by the reverse primer (purple). The two complementary strands are separated by 
size due to a polynucleotide tail (black) on the reverse primer separated by a hexaethylene 
glycol (HEG) spacer (grey) which terminates Taq polymerase-catalyzed synthesis of the 
pool sequences. 
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HEPES, pH 7.5 buffer which resulted in the slightly higher HEPES concentration for the 
SB selection. 
 Beginning in Round 5, a band corresponding to the cleavage product was observed 
for the SB selection (Zn2+ + Ce3+, Eu3+, Yb3+), corresponding to catalytic activity of 1.5% 
(Fig. 2.4). The activity continued to increase and reached the value of 36% at Round 7. 
When the selection step was performed with either Zn2+ alone or lanthanides alone, the 
catalytic activities observed were 25% and 0% (no DNA cleavage), respectively. The 
remaining selections, SA, SC and SD were iterated further; smearing at the locations of the 
activity bands appeared in Rounds 7–8 and persisted through Round 11, when these 
selections were terminated. 
 
“Winning” sequences (catalytically active sequences that survived the selection) 
from the 7SB selection step (round 7, SB selection) were amplified and cloned in E. coli. 
After picking 36 colonies and growing cell cultures, DNA vectors containing inserts of 
pool sequences were isolated. Sixteen vectors contained single inserts. After PCR 
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Figure 2.4: Progression of the SB selection experiment. 
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amplification, each sequence was screened by incubation with the single-stranded DNA 
substrate under selection conditions both with and without the three lanthanides to check 
whether or not these ions are required for catalysis. Six clones (7SB3, 6, 8, 25, 29 and 32) 
displayed catalytic activity even without Ce3+, Eu3+ and Yb3+ while four clones (7SB5, 17, 
20 and 23) required lanthanide ions (in addition to Zn2+) to facilitate DNA cleavage. After 
sequencing all of these clones, the lower-yielding 7SB20 sequence was found to be a single 
mutant of a more active 7SB5 clone (Fig. 2.5). The other three unique sequences of Ln3+-
dependent clones from the formerly random N40 region flanked by substrate-binding arms 
were then synthesized and assayed to determine their metal ion requirements and DNA 
cleavage yields. Catalytic activity of 7SB5 was much higher-yielding than that of the other 
two Ln3+-dependent deoxyribozymes which were set aside. Additional experiments 
revealed that 7SB5-catalyzed DNA cleavage occurs via a deglycosylation pathway instead 
of the expected hydrolysis reaction. The experimental details of this study are presented in 
Section 2.2.4 of this chapter, because the protocols were applicable to additional 
deoxyribozymes. Lanthanide-independent DNA catalysts requiring only Zn2+ for their 
activity that emerged from the SB selection were not studied further due to the indirect way 
of identifying these DNA enzymes in the presence of lanthanide ions. 
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Exploration of the ability to identify DNA-hydrolyzing deoxyribozymes without 
the redox-active Mn2+ was pursued further. A total of six selections, designated SL, SM, 
SN, SP, SQ and SR, were initiated. During the key selection steps, metal ions present 
during the 14 h incubations were as follows: Mg2+, Mn2+ and Zn2+ (SL), Mg2+ and Zn2+ 
(SM), Ca2+ and Zn2+ (SN), Mg2+ alone (SP), Ca2+ alone (SQ) and Mn2+ alone (SR); in all 
cases, the following metal ion concentrations were used: 40 mM Mg2+, 40 mM Ca2+, 
20 mM Mn2+ and 1 mM Zn2+. All selection reactions were performed in the presence of 
150 mM NaCl and either 50 mM CHES, pH 9.0 buffer (SP, SQ selections) or 70 mM 
HEPES, pH 7.5 buffer (SL, SM, SN, SR selections). The SL selection represented an 
internal positive control because it was performed under the conditions identical to those 
under which numerous DNA-hydrolyzing deoxyribozymes were identified. After four 
selection rounds, the initial activity, as manifested by appearance of a band aligning with 
the standard band on PAGE, was observed for SL, SM, SN and SR selections with pool 
yields between 4.0% and 7.7% (Fig. 2.6). The activity increased with yields above 35% for 
these four selections at Round 6. In both selections that did not have Zn2+ during the key 
Figure 2.5: Sequence alignment of catalytically active sequences that emerged from 
the SB selection. All residues identical to those of 7SB5 in the corresponding position 
are depicted as dots. 
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incubation step, the pools did not show catalytic activity through Round 8 and their 
progression was terminated. All catalytically active sequence pools except for the positive 
control (SL) selection were cloned from Round 5 PCR products. When sequencing results 
for DNA-cleaving clones were obtained, it was discovered that 20 out of the 24 sequences 
were either single mutants of or identical to one of the 7SB25, 7SB29 or 7SB32 sequences 
obtained in the previous selection effort that require only Zn2+ as the sole polyvalent metal 
ion cofactor. We postulate that these sequences contaminated the pools of the new 
selections and were amplified during PCR because both primer binding arms of the pools 
used for the SL-SR selections and the SB selection were identical. 
 
Because the potential ability of polyvalent metal ions to facilitate deoxyribozyme-
catalyzed DNA hydrolysis was still of great interest, in order to avoid a similar 
contamination problem in the future, a different primer-binding sequence was chosen. The 
original 15-nucleotides long reverse primer-binding sequence was scrambled (order of 
Figure 2.6: Progression of the SL, SM, SN and SR selection experiments. For each selection, 
the round at which individual deoxyribozymes were cloned is marked with an arrow on the 
plot. 
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individual nucleotides thoroughly reorganized) to give a new variant. A DNA pool 
containing the new region and reverse primer complementary to the new binding site were 
synthesized after verifying (with IDT OligoAnalyzer software) that no significant Watson-
Crick base-pairing interactions exist between them and the rest of the constant pool regions 
as well as the substrate sequence (Fig. 2.7). Because contaminating sequences were 
propagated during PCR, changing one of the primer regions for the new selections was 
expected to prevent their amplification. Sequence modifications were not performed on 
either of the substrate-binding arms, one of which also serves to base-pair with the forward 
primer during PCR. 
 
The new pool design was used in the next selection efforts where trivalent 
(lanthanides) and divalent (Zn2+, Mg2+, Ca2+, Mn2+) metal ions were evaluated for their 
ability to facilitate DNA hydrolysis by deoxyribozymes. Eight selections were initiated in 
total: four of these were with 1 mM Zn2+ and either one of 10 M Ce3+, Eu3+ and Yb3+ or 
a mix of all three lanthanide ions each at 3 M concentration. The other selections had 
either 1 mM Zn2+ alone or with one of 40 mM Mg2+ or Ca2+; redox-active 20 mM Mn2+ as 
the sole polyvalent metal ion cofactor was also evaluated. Selection reactions were 
incubated in the presence of either 70 mM (WA-WG) or 50 mM (WH) HEPES, pH 7.5 
buffer and 150 mM NaCl. All incubations were performed for 12 h at 37 °C. The bands 
with appropriate PAGE shifts indicating single-stranded DNA substrate cleavage first 
Figure 2.7: An approach to avoid PCR-propagated contamination. Original reverse primer 
(purple) and its complementary constant region of the pool (brown) sequences were 
changed (red). 
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appeared in Round 5 for six out of eight selections and accounted for 3.3% to 8.3% of 
overall intensity in each lane (Fig. 2.8). Once pool yields increased above a threshold of 
~20%, the appropriate pool sequences were cloned. After initial screening and sequencing 
of catalytically active clones from selections WA and WB, the same contaminating 
sequences as in the previous selection efforts were discovered. This observation meant that 
the reverse primer substitution approach was insufficient to prevent propagation of the 
contaminants which originated in the SB selection. Although lacking the appropriate 
primer-binding sequence, these Zn2+-dependent DNA catalysts were still copied during 
PCR: even a single reverse complement could give rise to many copies of the 
contaminating sequences. The fact that the substrate-binding regions as well as the 
incubation conditions for all described selection experiments starting with the SB effort 
were identical means that the contaminating sequences survived the selection en masse, 
dominated the pools from early rounds and prevented the emergence of novel catalysts. 
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Figure 2.8: Progression of the WA-WH selection experiments. For each selection, the round 
at which individual deoxyribozymes were cloned is marked with an arrow on the plot. 
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To prevent the possibility of contamination during the subsequent selection efforts, 
large portions of both substrate-binding arm sequences of the pool were changed (Fig. 2.9). 
Only the three nucleotides flanking the N40 random region in each arm remained 
unchanged. A single-stranded DNA substrate sequence complementary to the new binding 
arms was prepared; the single unpaired C nucleotide remained in the new design. This 
redesign also necessitated the use of a different forward primer complementary to the new 
pool’s constant region sequence. Using the IDT OligoAnalyzer software, the old substrate 
binding arms were verified to have no significant base-pairing interaction with the new 
substrate sequence. With this design, any contaminating sequence that originated in one of 
the previous selection efforts is prevented from binding the new substrate sequence and is 
therefore rendered incapable of propagating from one round to the next.  
 
Using the redesigned random pools and complementary substrates, eight new 
selection experiments, designated YE-YM, were initiated. Four of these selections used 
1 mM Zn2+ and either one of 10 M Ce3+ (YJ), Eu3+ (YK) and Yb3+ (YL) or a mix of all 
three lanthanide ions each at 3 M concentration (YH). The other selections had either 
1 mM Zn2+ alone (YE) or one of 40 mM Mg2+ (YF) or Ca2+ (YG); redox-active 
20 mM Mn2+ as the sole polyvalent metal ion cofactor was also evaluated (YM). Selection 
reactions were incubated in the presence of either 70 mM (YE-YL) or 50 mM (YM) 
HEPES, pH 7.5 buffer and 150 mM NaCl. All incubations were performed for 12 h at 
Figure 2.9: An approach to avoid contamination. Original single-stranded DNA substrate 
(blue) and its complementary constant regions of the pool (brown) as well as forward primer 
(pink) sequences were changed (red). 
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37 °C. Each experiment was iterated for numerous selection rounds, leading to substantial 
DNA cleavage activity by rounds 5 through 7; the progress of selections is presented in 
Fig. 2.10. Sequences from seven out of eight selection pools were cloned at rounds 6, 7 or 
8; due to redundancy, the YH selection (Zn2+ + Ce3+, Eu3+, Yb3+), was not studied further. 
After screening and sequencing of individual clones, no contamination from previous 
selections efforts was observed. All of the new sequences (Fig. 2.11), therefore, are likely 
to have arisen from the current selection experiments. Unique sequences from formerly 
random N40 regions flanked by substrate-binding arms were then synthesized and assayed 
to determine their metal ion requirements, cleavage site specificity and initial rate kinetics. 
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Figure 2.10: Progression of the YE-YM selection experiments. For each selection, the round 
at which individual deoxyribozymes were cloned is marked with an arrow on the plot. 
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2.2.3 DNA-catalyzed DNA hydrolysis in the presence of lanthanide ions 
 For all three selection experiments with Zn2+ and one of Ce3+, Eu3+ and Yb3+, all of 
the individual deoxyribozymes were found to require lanthanide ions and to catalyze site-
specific DNA hydrolysis. Two deoxyribozymes emerged from the selection with Zn2+ + 
Ce3+: 6YJ10 and 6YJ14 (YJ selection cloned after 6 rounds, clones number 10 and 14). 
Both DNA catalysts hydrolyzed the phosphodiester bond at the 5ʹ-carbon of the unpaired 
Figure 2.11: Sequences of the initially random (N40) catalytic regions. Each 
functional deoxyribozyme comprises the listed catalytic region, surrounded by 
two Watson-Crick binding arms that interact with the single-stranded DNA 
substrate. 
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C nucleotide, creating 3ʹ-phosphate and 5ʹ-hydroxyl termini, consistent with mass 
spectrometry results and with the PAGE standard ladder (Fig. 2.12). The same 
oligonucleotide standards series was loaded on each assay gel. These standards provide a 
common reference point for comparing gel images and a basis for preliminary assignment 
of reaction products, albeit with some ambiguity due to near-coincident migration of 
(i) oligonucleotides of length n with 3′-hydroxyl and (ii) oligonucleotides of length n+1 
with 3′-phosphate (greater mass reduces the migration rate, whereas greater charge 
increases the migration rate). Additionally, both deoxyribozymes had trace catalytic 
activity when Ce3+ was substituted with Eu3+ and no activity detected with Yb3+. Kinetic 
plots for 6YJ10 and 6YJ14 are presented in Fig. 2.14. 
 
  
Figure 2.12: Assays of 6YJ10 and 6YJ14 deoxyribozymes that catalyze DNA 
hydrolysis from the YJ selection experiment that used Zn2+ + Ce3+ (t = 30 s, 1 h, 16 h). 
Assays were in 70 mM HEPES, pH 7.5, 1 mM ZnCl2, 10 µM LnCl3 and 150 mM NaCl at 
37 °C. See Table 2.2 for all mass spectrometry data values. Definitive assignment of 
reaction products was made on the basis of the mass spectrometry data. 
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A total of three deoxyribozymes emerged from selection with Zn2+ + Eu3+: 7YK24, 
7YK34 and 7YK35. Each catalyst hydrolyzed a different phosphodiester bond in the 
substrate sequence; one DNA enzyme, 7YK34, created 5ʹ-phosphate and 3ʹ-hydroxyl 
termini on the strands after the hydrolytic cleavage while the other two deoxyribozymes 
yielded 3ʹ-phosphate and 5ʹ-hydroxyl termini (Fig. 2.13). Cleavage sites are consistent with 
mass spectrometry results and with the PAGE standard ladder. Both 7YK34 and 7YK35 
displayed strong catalytic activity in the presence of either Ce3+ or Yb3+ in place of the 
parental Eu3+ ion. Interestingly, 7YK24 was more active and had a faster rate when Eu3+ 
was substituted with Yb3+; no detectable hydrolysis was observed with Ce3+. Kinetic plots 
are presented in Fig. 2.15. 
 
  
Figure 2.13: Assays of 7YK24, 7YK34 and 7YK35 deoxyribozymes that catalyze DNA 
hydrolysis from the YK selection experiment that used Zn2+ + Eu3+ (t = 30 s, 1 h, 16 h). Assays 
were in 70 mM HEPES, pH 7.5, 1 mM ZnCl2, 10 µM LnCl3 and 150 mM NaCl at 37 °C. See 
Table 2.2 for all mass spectrometry data values. Definitive assignment of reaction products 
was made on the basis of the mass spectrometry data. 
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Figure 2.14: Kinetic plots for 6YJ10 and 6YJ14 deoxyribozymes from the YJ selection with 
Zn2+ + Ce3+. kobs values from the first-order curve fits are presented in Table 2.1. 
6YJ10 6YJ14 
Figure 2.15: Kinetic plots for 7YK24, 7YK34 and 7YK35 deoxyribozymes from the YK 
selection with Zn2+ + Eu3+. kobs values from the first-order curve fits are presented in 
Table 2.1. 
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A total of four deoxyribozymes emerged from the selection with Zn2+ + Yb3+: 
6YL4, 6YL11, 6YL24 and 6YL34. Two different phosphodiester bonds in the substrate 
sequence were hydrolyzed, each by two different catalysts. All of the 6YL DNA enzymes 
created 3ʹ-phosphate and 5ʹ-hydroxyl termini after hydrolysis (Fig. 2.15). Cleavage sites 
are consistent with mass spectrometry results and with the PAGE standard ladder. When 
evaluated with Zn2+, two out of four deoxyribozymes (6YL4 and 6YL24) had detectable 
catalytic activity when the parental Yb3+ ion was substituted for Eu3+, and no activity was 
observed with Ce3+. 
 All nine of the new lanthanide-dependent deoxyribozymes were then separately 
assayed with the lanthanide ion as the sole polyvalent metal ion cofactor, in the absence of 
Zn2+ despite its presence during selection (50 mM HEPES, pH 7.5, 150 mM NaCl, 37 °C). 
Both of the Ce3+-dependent deoxyribozymes, all three of the Eu3+-dependent DNA 
enzymes and two of the four Yb3+-dependent DNA catalysts had no detectable activity 
without Zn2+, even when 40 mM Mg2+ was included to maintain high ionic strength (data 
not shown). However, two of the Yb3+-dependent deoxyribozymes, 6YL4 and 6YL24, had 
substantial activity with Yb3+ alone in the absence of Zn2+, similar in each case to the 
activity with Yb3+ in the presence of Zn2+ (Fig. 2.15). These Yb3+-only activities were 
maintained in the presence of 40 mM Mg2+ (data not shown). Catalysis by both 6YL4 and 
6YL24 was achieved by Yb3+ alone (no Zn2+) with Kd,app on the order of 10 µM, whereas 
Eu3+ was much less effective and Ce3+ did not support detectable activity. Kinetic plots are 
presented in Fig. 2.17. 
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Figure 2.16: Assays of 6YL4, 6YL11, 6YL24 and 6YL34 deoxyribozymes that catalyze DNA 
hydrolysis from the YL selection experiment that used Zn2+ + Yb3+ (t = 30 s, 1 h, 16 h). Assays 
were in 70 mM HEPES, pH 7.5, 1 mM ZnCl2, 10 µM LnCl3 (if included) and 150 mM NaCl at 
37 °C. See Table 2.2 for all mass spectrometry data values. Definitive assignment of reaction 
products was made on the basis of the mass spectrometry data. 
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The sharp dependence of many new deoxyribozymes on the lanthanide ion identity 
is remarkable. We hypothesize that this observation is due to the difference of radius among 
the three trivalent lanthanide ions (Ce3+ > Eu3+ > Yb3+). In their tertiary structures, 
deoxyribozymes identified with a specific lanthanide ion, may have a binding pocket that 
matches the size of that particular ion. In the case of the Ce3+-dependent 6YJ10 and 6YJ14 
deoxyribozymes, substitution of Ce3+ with a smaller Eu3+ ion significantly inhibits their 
activity, while they are inactive with an even-smaller Yb3+. We infer that the lanthanide 
ions with smaller radii cannot coordinate properly in the large binding pockets of 6YJ10 
and 6YJ14 to support catalysis (Figs. 2.12 and 2.14). We observe the same trend, but in the 
opposite direction, for all four DNA catalysts selected with Yb3+ (Figs. 2.16 and 2.17). 
  
Figure 2.17: Kinetic plots for 6YL4, 6YL11, 6YL24 and 6YL35 deoxyribozymes from the YL 
selection with Zn2+ + Eu3+. kobs values from the first-order curve fits are presented in 
Table 2.1. 
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deoxyribozyme metal ions kobs, h–1 yield, % 
6YJ10 Zn2+/Ce3+ 0.38 69 
 Zn2+/Eu3+ 0.0060 a 10 
6YJ14 Zn2+/Ce3+ 0.11 67 
 Zn2+/Eu3+ 0.0072 a 27 
7YK24 Zn2+/Eu3+ 0.028 28 
 Zn2+/Yb3+ 0.098 63 
7YK34 Zn2+/Ce3+ 0.091 59 
 Zn2+/Eu3+ 0.071 55 
 Zn2+/Yb3+ 0.044 40 
7YK35 Zn2+/Ce3+ 0.096 53 
 Zn2+/Eu3+ 1.46 79 
 Zn2+/Yb3+ 1.15 72 
6YL4 Zn2+/Yb3+ 0.055 25 
6YL11 Zn2+/Yb3+ 0.19 55 
6YL24 Zn2+/Eu3+ <0.003 a 2 
 Zn2+/Yb3+ 0.18 53 
6YL34 Zn2+/Yb3+ 0.17 64 
6YL4 Eu3+ 0.0015 a 5 
6YL4 Yb3+ 0.038 ± 0.009 b 48 ± 3 b 
6YL24 Eu3+ 0.0036 a 15 
6YL24 Yb3+ 0.057 ± 0.020 b 71 ± 11 b 
 
Table 2.1: kobs and yield values for the data plotted in Figs. 2.14, 2.15 and 2.17. kobs values 
are from first-order kinetic fits unless otherwise noted. Yield values were observed at the 
48 h timepoints. 
a kobs values are from linear fits to the initial time points. 
b Values represent mean ± sd from four independent experiments. 
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deoxy-
ribozyme a 
metal ion 
cofactor(s) 
mass 
L calcd. 
mass 
L found 
L error, % 
(found –  
calcd.) 
mass 
R calcd. 
mass 
R found 
R error, % 
(found –  
calcd.) 
6YJ10 Zn2+/Ce3+ 7648.0 7648.0 0 5603.7 5602.4 –0.02 
6YJ14 Zn2+/Ce3+ 7648.0 7648.2 +0.003 5603.7 5604.6 +0.02 
7YK24 Zn2+/Eu3+ 7648.0 7652.2 +0.05 5603.7 5606.4 +0.05 
7YK34 Zn2+/Eu3+ 8186.4 8188.0 +0.02 5065.3 5066.2 +0.02 
7YK35 Zn2+/Eu3+ 7937.2 7937.4 +0.003 5314.5 5315.6 +0.02 
6YL4 Zn2+/Yb3+ 7937.2 7940.2 +0.04 5314.5 5316.1 +0.03 
6YL4 Yb3+ 7937.2 7934.9 –0.03 5314.5 5312.1 –0.05 
6YL11 Zn2+/Yb3+ 7343.8 7345.4 +0.02 5907.9 5909.8 +0.03 
6YL24 Zn2+/Yb3+ 7937.2 7939.0 +0.02 5314.5 5315.7 +0.02 
6YL24 Yb3+ 7937.2 7936.2 –0.01 5314.5 5313.4 –0.02 
6YL34 Zn2+/Yb3+ 7343.8 7346.1 +0.03 5907.9 5910.0 +0.04 
7YE11 Zn2+ 7568.0 7568.4 +0.01 5683.7 5684.3 +0.01 
8YG11 Zn2+ 8186.4 8189.7 +0.04 5065.3 5067.4 +0.04 
 
Table 2.2: Mass spectrometry assays of cleavage products for DNA-hydrolyzing 
deoxyribozymes. 
a See Fig. 2.12 (6YJ deoxyribozymes, Zn2+/Ce3+), Fig. 2.13 (7YK deoxyribozymes, Zn2+/Eu3+), 
Fig. 2.16 (6YL deoxyribozymes, Zn2+/Yb3+ or Yb3+ alone) and Fig. 2.23 (7YE11, Zn2+; 8YG11, 
Zn2+/Ca2+) for each deoxyribozyme’s assigned hydrolysis site. 
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 The lanthanide ion concentration dependence of each deoxyribozyme was 
evaluated with the lanthanide ion used during the selection process along with 1 mM Zn2+, 
except for the three 7YK DNA catalysts. For 7YK24, the Yb3+ concentration dependence 
was evaluated because in the presence of this lanthanide, the activity of 7YK24 was 
significantly higher than with Eu3+, the ion with which this deoxyribozyme was selected. 
Because both 7YK34 and 7YK35 displayed appreciable catalytic activity with all three 
lanthanide ions, concentration dependence of these DNA catalysts was assayed for each of 
Ce3+, Eu3+ and Yb3+. When 1 mM Zn2+ was present, the optimal lanthanide ion 
concentration for each new deoxyribozyme was ~10 M. In the absence of 1 mM Zn2+, 
6YL4 and 6YL24, which only require lanthanides as polyvalent metal ion cofactors, each 
displayed a similar level of catalytic activity with 10 and 30 M Yb3+. Kinetic plots are 
presented in Figs. 2.18-2.21. 
 
  
Figure 2.18: Assays of 6YJ10 and 6YJ14 at 1 mM Zn2+ and 3, 10, 30 M Ce3+. 
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Figure 2.19: Assays of 7YK24, 7YK34 and 7YK35 at 1 mM Zn2+ 
and 3, 10, 30 M Ce3+, Eu3+ or Yb3+. 
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Figure 2.20: Assays of 6YL4, 6YL11, 6YL24, 6YL34 at 1 mM Zn2+ and 3, 10, 30 M Yb3+. 
Figure 2.21: Assays of 6YL4 and 6YL24 at 3, 10, 30, 60 or 100 M Yb3+ in the absence of Zn2+. 
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 The dependence of 6YL4 and 6YL24 activity on Yb3+ concentration, in the absence 
of Zn2+, was also quantified by yields at 48 h (Fig. 2.22). The highest yields were achieved 
at ~10–20 M Yb3+, whereas steady decrease of activity was observed at higher Yb3+ 
concentrations. 
 
To create the plots in the above figure, each data set was fit to the following equation: 
𝑌 = 𝑌max ∙
𝐶𝑛
𝐾activ
𝑛 + 𝐶𝑛
∙ (1 −
𝐶𝑚
𝐾inhib
𝑚 + 𝐶𝑚
) 
where Y = yield, C = Yb3+ concentration, Kactiv and Kinhib are apparent binding constants for 
Yb3+ activation and inhibition, respectively, and n and m are Hill coefficients for Yb3+ 
binding and activation, respectively. This equation was derived from a model in which n 
activating Yb3+ ions must bind for the deoxyribozyme to adopt a productive conformation 
for catalysis, whereas m inhibitory Yb3+ ions must not bind for the deoxyribozyme to adopt 
Figure 2.22: Plots of dependence of 6YL4 and 6YL24 
catalytic activity on Yb3+ concentration as 
quantified by yields at 48 h. 
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an productive conformation and, moreover, binding of the n activating and m inhibitory 
Yb3+ ions are independent events (and therefore the relevant probabilities multiply). Fit 
values were as follows: 6YL4 Ymax 62%, Kactiv 9 µM, Kinhib 44 µM, n 14, m 6; 6YL24 
Ymax 75%, Kactiv 8 µM, Kinhib 55 µM, n 14, m 6. The precise numerical values are less 
important than the overall finding that data for both deoxyribozymes are fit well by a simple 
model in which Yb3+ activation is highly cooperative with ~10 µM apparent binding 
constant and Yb3+ inhibition is somewhat less cooperative with several-fold higher 
apparent binding constant. We cannot discount the possibility that the “inhibition” 
observed at high Yb3+ concentration is instead a nonspecific effect due to Yb3+ precipitation 
or aggregation rather than true inhibition via binding of Yb3+ to the deoxyribozyme. 
However, we have no particular evidence for Yb3+ precipitation or aggregation, and others 
have probed deoxyribozyme activity with lanthanide ions at concentrations considerably 
higher than we have used here (up to 1.5 mM at pH 7.0).11 
 Because of the prior report of a Pb2+-dependent DNA enzyme that can use 
lanthanide ions in place of Pb2+,11-18 for each of the new deoxyribozymes we also evaluated 
replacement of the lanthanide ion with 1 mM Pb2+, either with or without the additional 
inclusion of Zn2+; in all cases, no activity was observed. Also, because each of Ce3+, Eu3+ 
and Yb3+ have accessible 2+ oxidation states,19 we checked the activities of each of the 
nine new lanthanide-dependent deoxyribozymes with La3+, Gd3+ and Lu3+, each of which 
is adjacent to one of Ce3+, Eu3+, or Yb3+ (respectively) but cannot readily access its 2+ 
oxidation state. In all cases, substantial DNA hydrolysis activity was retained, indicating 
that the catalysis does not depend upon accessing the lanthanide 2+ oxidation state. 
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2.2.4 DNA-catalyzed DNA cleavage in the absence of lanthanide ions 
 DNA catalysts identified from the four selections without lanthanide metal ions 
were also characterized. Only two deoxyribozymes were found to catalyze phosphodiester 
bond hydrolysis: 7YE11 (from the Zn2+-alone selection) and 8YG11 (from the Zn2+ + Ca2+ 
selection) (Fig. 2.23).  The remaining 18 DNA enzymes catalyze deglycosylation (cleavage 
of the N-glycosidic bond), eventually leading to single-stranded DNA strand scission after 
two spontaneous -elimination reactions. The two reactivities can be discerned by MALDI 
mass spectrometry because the sets of two cleavage products from each mechanism are not 
Figure 2.23: Assays of two DNA-hydrolyzing deoxyribozymes identified in the 
absence of lanthanide ion cofactors. Representative timepoints at t = 30 s, 30 min, 
2 h and 16 h under single-turnover conditions. (a) 7YE11 deoxyribozyme, 
identified with Zn2+ alone. (b) 8YG11 deoxyribozyme, identified with Zn2+ + Ca2+. 
Presentation of data is similar to that shown in Figs. 2.12, 2.13 and 2.16. 
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identical: deglycosylation results in a loss of one nucleobase and one sugar residue while 
there is no loss of functional groups due to hydrolytic cleavage of a phosphodiester bond 
(Fig. 2.24). 
 
 All but one (8YM4) of these DNA enzymes catalyze non site-specific 
deglycosylation of nucleobases at multiple positions within the central region of the 
substrate sequence, including the unpaired C (Fig. 2.25). 8YM4 site-specifically 
Figure 2.24: Comparison of two pathways for DNA cleavage. 
(a) Hydrolysis, leading to either 3′-hydroxyl + 5′-phosphate 
termini (shown) or 3′-phosphate + 5′-hydroxyl termini (not 
shown). (b) Deglycosylation followed by strand scission via two 
-elimination reactions, leading to 3′-phosphate + 5′-phosphate 
termini and a “missing” nucleoside. B = nucleobase. 
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deglycosylates the G nucleobase directly to the right of the unpaired nucleotide. Most of 
these DNA catalysts cleave the glycosidic bonds of either one of two adjacent nucleotides; 
8YM20 acts on one of three adjacent nucleobases. Many deoxyribozymes with two 
cleavage sites display a preference for one nucleobase over the other. Observation of 
depurination and depyrimidination at adjacent nucleotides (e.g., 8YM17 or 8YM26; 
Fig. 2.26) catalyzed by the same deoxyribozyme suggests a deglycosylation mechanism 
that is indifferent to the structure of the nucleobase, but more studies are needed to probe 
these mechanism(s). The finding of depyrimidination (at T or C) rather than depurination 
Figure 2.25: Assays of 8YM4, 8YM17, 8YM20 and 8YM26 deoxyribozymes that catalyze DNA 
cleavage by deglycosylation and -elimination from the YM selection experiment that used 
Mn2+ alone (t = 30 s, 30 min, 2 h, 16 h). The arrows above each sequence mark the site(s) of 
deglycosylation, as assigned on the basis of the MALDI mass spectrometry data. 
Nucleotides are numbered as part of either the L (left) or R (right) portion of the substrate, 
counting outward. See Table 2.3 for all mass spectrometry data values. Mass spectrometry 
peaks labeled S correspond to uncleaved substrate (z = 2). In all cases, the assigned 
deglycosylation sites were consistent with the PAGE standard ladders. Definitive 
assignment of reaction products was made on the basis of the mass spectrometry data. 
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(at A or G) by 8YM17 and 8YM26 (Fig. 2.26) as well as several of the Zn2+/Ca2+-dependent 
deoxyribozymes (Fig. 2.28) is especially curious. Depyrimidination is generally more 
difficult to catalyze than is depurination, because pyrimidine nucleobases lack the purine 
N7 atom that can be protonated or otherwise activated to assist deglycosylation.20,21 
Although the uncatalyzed deglycosylation rates of purine and pyrimidine nucleosides in 
DNA are similar22 and uracil DNA glycosylase is well known for damage repair,23-27 
natural enzymatic examples of depyrimidination of cytidine or its analogues are 
unommon.21,28,29 
 Although loading PAGE standard ladders alongside assay samples afforded a good 
estimate of the cleavage site location within the substrate, masses of product fragments 
obtained by MALDI provided truly conclusive evidence. In several cases, the left-hand (L) 
product formed upon deglycosylation and -elimination was observed as an L+58 peak, 
i.e., a peak with mass 58 higher than expected for the L product with a simple 3′-phosphate 
group. Typically both the L and L+58 peaks were observed. Per Fig. 2.24, the first -
elimination reaction after deglycosylation releases the right-hand (R) oligonucleotide 
product, which is always observed cleanly by mass spectrometry in its simple 5′-phosphate 
form. The ensuing, second -elimination reaction should release L. However, if the excised 
nucleoside sugar ring (red in Fig. 2.24) is partially fragmented rather than fully released 
from the L product fragment, then the L product fragment will have slightly higher mass 
than expected. There is precedent for such partial sugar fragmentation, at least for 
oxidatively induced DNA cleavage reactions.30,31 In the present examples, although the 
available metal ions—either Zn2+ alone or Zn2+ with Mg2+ or Ca2+—are not redox-active, 
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we speculate that a similar sugar ring fragmentation occurs (via unknown mechanism), 
leading to the observed L+58 = L+C2H2O2 products. 
 One of the five deoxyribozymes identified from selections with Zn2+ alone, 7YE11, 
catalyzes phosphodiester bond hydrolysis. Three of the other four DNA catalysts (7YE5, 
7YE8, 7YE19) preferably facilitate depurination of the G nucleobase immediately adjacent 
to the unpaired nucleotide while the neighboring A is the secondary deglycosylation site. 
For 7YE2, the depurination sites are the same, but site preferences are reversed (Fig. 2.26). 
 
  
Figure 2.26: Assays of 7YE2, 7YE5, 7YE8, 7YE19 deoxyribozymes that catalyze DNA 
deglycosylation and -elimination from the YE selection experiment that used Zn2+ (t = 30 s, 
30 min, 2 h, 16 h). The arrows above each sequence mark the site(s) of deglycosylation, as 
assigned on the basis of the MALDI mass spectrometry data. Nucleotides are numbered as 
part of either the L (left) or R (right) portion of the substrate, counting outward. See Table 2.3 
for all mass spectrometry data values. Mass spectrometry peaks labeled S correspond to 
uncleaved substrate (z = 2). In all cases, the assigned deglycosylation sites were consistent 
with the PAGE standard ladders. Definitive assignment of reaction products was made on 
the basis of the mass spectrometry data. 
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 All deoxyribozymes identified from the selection with Zn2+ and Mg2+ have the same 
deglycosylation site specificities but vary in terms of site preference (Fig. 2.27). These 
DNA catalysts were evaluated with Zn2+ alone, with Zn2+ + Mg2+ and with Zn2+ + Ca2+. 
6YF2, 6YF 15 and 6YF 27 are more active with Zn2+ + Mg2+ than with Zn2+ alone or Zn2+ 
+ Ca2+. In contrast, 6YF13, 6YF 16 and 6YF 20 have nearly equivalent activity with Zn2+ 
alone and Zn2+ + Mg2+, and they are slightly suppressed by Ca2+ (Fig. 2.27). 
Figure 2.27: Assays of 6YF2, 13, 15, 16, 20, 27 deoxyribozymes that catalyze DNA 
deglycosylation from the selection experiment that used Zn2+ + Mg2+ (t = 30 s, 30 min, 2 h, 
16 h). The arrows above each sequence mark the site(s) of deglycosylation, as assigned on 
the basis of the MALDI mass spectrometry data. See Table 2.3 for all mass spectrometry 
data values (for products formed using Zn2+ + Mg2+). In all cases, the assigned 
deglycosylation sites were consistent with the PAGE standard ladders. Definitive 
assignment of reaction products was made on the basis of the mass spectrometry data. 
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 Deoxyribozymes identified from the selection with Zn2+ and Ca2+ display a range 
of deglycosylation site specificities and site preferences, with one example, 8YG24, 
equally active towards both the unpaired C and its adjacent T nucleobase. 8YG1 and 8YG7 
catalyze depyrimidination of the same nucleobases as 8YG24. 8YG7 depurinates the 
adjacent A nucleobases to the right of the unpaired nucleotide. These DNA catalysts were 
tested under selection conditions and with Zn2+ alone as well as with Zn2+ + Mg2+. 8YG1 
and 8YG24 clearly require Zn2+ + Ca2+ for activity. 8YG7 is more active with Zn2+ + Mg2+ 
than with Zn2+ alone or Zn2+ + Ca2+. 8YG29 is inactive with Zn2+ alone and approximately 
equally active with Zn2+ + Mg2+ and Zn2+ + Ca2+ (Fig. 2.28). 
 
 
Figure 2.28: Assays of 8YG1, 8YG7, 8YG24 and 8YG29 deoxyribozymes that catalyze DNA 
deglycosylation and -elimination from the selection experiment that used Zn2+ + Ca2+ 
(t = 30 s, 30 min, 2 h, 16 h). The arrows above each sequence mark the site(s) of 
deglycosylation, as assigned on the basis of the MALDI mass spectrometry data. 
Nucleotides are numbered as part of either the L (left) or R (right) portion of the substrate, 
counting outward. See Table 2.3 for all mass spectrometry data values (for products formed 
using Zn2+ + Ca2+). Mass spectrometry peaks labeled S correspond to uncleaved substrate 
(z = 2); mass spectrometry peaks labeled X were unassigned and not reproducibly observed. 
In all cases, the assigned deglycosylation sites were consistent with the PAGE standard 
ladders. Definitive assignment of reaction products was made on the basis of the mass 
spectrometry data. 
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deoxy-
ribozyme 
deglycos. 
site(s) a 
mass 
L calcd. 
mass 
L found 
L error, % 
(found –  
calcd.) 
mass 
R calcd. 
mass 
R found 
R error, % 
(found –  
calcd.) 
8YM4 G(R1): L, R 7937.2 7936.2 -0.01 5065.3 5065.0 -0.01 
8YM17 T(L1): L, R 7343.8 7343.8 0 5683.7 5682.8 -0.02 
 A(L2): L′, R′ 7030.6 7029.9 -0.01 5987.9 5987.8 -0.002 
8YM20 G(R1): L, R 7937.2 7940.9 +0.05 5065.3 5067.2 +0.04 
 A(R2): L′, R′ 8266.4 not obs. — 4752.1 4754.2 +0.04 
 A(R3): L′′, R′′ 8579.6 8574.5 -0.06 4438.9 4441.1 +0.05 
8YM26 T(L1): L, R 7343.8 7347.2 +0.05 5683.7 5686.5 +0.05 
 A(L2): L′, R′ 7030.6 7034.0 +0.05 5987.9 5991.6 +0.06 
7YE2 A(R2): L, R 8266.4 8262.6 -0.05 4752.1 4749.9 -0.05 
 G(R1): L′, R′ 7937.2 not obs. — 5065.3 5062.6 -0.05 
7YE5 G(R1): L, R b 7995.2 7993.9 -0.02 5065.3 5064.8 -0.01 
7YE8 G(R1): L, R b 7995.2 7997.4 +0.03 5065.3 5064.3 -0.02 
7YE19 G(R1): L, R b 7995.2 7994.7 -0.01 5065.3 5065.7 +0.01 
6YF2 A(R2): L, R 8266.4 8267.6 +0.01 4752.1 4752.8 +0.01 
 G(R1): L′, R′ 7937.2 not obs. — 5065.3 5066.5 +0.02 
6YF13 G(R1): L, R b 7995.2 7992.2 -0.04 5065.3 5064.4 -0.02 
6YF15 A(R2): L, R 8266.4 8258.9 -0.09 4752.1 4747.4 -0.10 
6YF16 A(R2): L, R 8266.4 8266.2 -0.002 4752.1 4752.7 +0.01 
 G(R1): L′, R′ b 7995.2 not obs. —  5065.3 5066.1 +0.02 
6YF20 A(R2): L, R 8266.4 8268.5 +0.03 4752.1 4753.2 +0.02 
6YF27 A(R2): L, R 8266.4 8264.4 -0.02 4752.1 4750.8 -0.03 
8YG1 C(unp): L, R 7648.0 7650.6 +0.03 5394.5 5396.9 +0.04 
8YG7 A(R2): L, R b 8324.4 8334.2 +0.12 4752.1 4756.9 +0.10 
8YG24 C(unp): L, R 7648.0 7648.6 +0.01 5394.5 5394.5 0 
 T(L1): L′, R′ b 7401.8 7402.0 +0.003 5683.7 5684.1 +0.01 
8YG29 C(unp): L, R 7648.0 7650.8 +0.04 5394.5 5396.5 +0.04 
 
Table 2.3: Mass spectrometry assays of cleavage products for DNA-deglycosylating 
deoxyribozymes. 
a See Fig. 2.25 (8YM deoxyribozymes, Mn2+), Fig. 2.26 (7YE deoxyribozymes, Zn2+), Fig. 2.27 
(6YF deoxyribozymes, Zn2+/Mg2+) and Fig. 2.28 (8YG deoxyribozymes, Zn2+/Ca2+) for 
assigned deglycosylation site(s). Some of the secondary deglycosylation sites observed by 
PAGE were sufficiently weak such that no corresponding product peaks could be observed 
by mass spectrometry; a row is omitted altogether for these secondary sites. In addition, 
the L peaks for several of the secondary sites were not observed, although the R peaks were 
observed; these instances are denoted by “not obs.” in the table. 
b In this case, the L product peak was observed primarily in the L+58 form. The L calcd. 
value was computed from the initially expected L value by adding the mass of C2H2O2. 
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2.3 Summary 
 In this chapter, in vitro selection, an artificial evolution process, was used to 
identify single-stranded DNA-cleaving deoxyribozymes starting from a pool of random 
sequences. We evaluated the ability of numerous polyvalent metal ions at different 
concentrations (ranging from micromolar to milimolar) to support catalytic activity of 
DNA enzymes. Due to several unforeseen complications during this work, improvements 
to the in vitro selection design were made. 
 Initially, an existing DNA-hydrolyzing deoxyribozyme was tested in the presence 
of trivalent lanthanide ions. Although it was concluded that these metal ions cannot support 
catalysis by this deoxyribozyme, an important discovery was made. Zn2+ was shown to be 
the sole required polyvalent metal ion cofactor for this DNA catalyst initially believed to 
also require Mn2+ for its activity. In subsequent work, contamination by catalytic DNA 
sequences found in earlier efforts subverted the process of new deoxyribozyme 
identification via in vitro selection. Full redesign of one primer-binding region still allowed 
for contaminating sequences to propagate. Only substantial modification of both fixed 
substrate-binding sequences prevented contamination. This principle has been applied in 
all subsequent work in the Silverman laboratory. 
Using the new methodology, new selection experiments were initiated. The key 
selection step was performed in the presence of 10 µM lanthanide ion (Ce3+, Eu3+, or Yb3+) 
along with 1 mM Zn2+. We identified numerous DNA-hydrolyzing deoxyribozymes, most 
of which strictly require the lanthanide ion as well as Zn2+ for catalytic activity. These DNA 
catalysts have a range of lanthanide dependences, including some deoxyribozymes that 
strongly favor one particular lanthanide ion. Typically, a DNA catalyst’s preferred 
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lanthanide was present in the selection experiment from which this catalyst was identified. 
DNA enzymes that function well with more than one lanthanide ion were also found. 
Intriguingly, two of the Yb3+-dependent deoxyribozymes function well with Yb3+ alone 
(Kd,app ~10 µM, in the absence of Zn
2+) and have little or no activity with Eu3+ or Ce3+. In 
contrast to these selection outcomes when lanthanide ions were present, new selections 
with Zn2+ or Mn2+ alone, or Zn2+ with Mg2+/Ca2+, led primarily to deoxyribozymes that 
cleave single-stranded DNA by deglycosylation and -elimination rather than by 
hydrolysis, including several instances of depyrimidination. 
 
2.3.1 Implications for future selection efforts 
The two orders of magnitude concentration difference between 10 µM lanthanide 
and 1 mM Zn2+ may enable new applications of deoxyribozymes, particularly in contexts 
where high polyvalent metal ion concentrations must be avoided. Future efforts should 
pursue direct identification of new deoxyribozymes that require only lanthanide ions by 
including lanthanides as the sole polyvalent metal ions present during the selection process. 
Efforts that include increased time pressure for faster reactivity may also be beneficial, 
considering that most of the new deoxyribozymes have half-lives on the order of several 
hours, although the fastest lanthanide-dependent deoxyribozymes have half-lives of 
ca. 0.5 h (Table 2.1). In general, on the basis of our overall findings, lanthanide ions deserve 
closer attention as metal ion cofactors when developing new nucleic acid catalysts. For the 
DNA-cleaving deoxyribozymes that were identified by selection in the presence of Mn2+ 
alone, Zn2+ alone, or Zn2+ with Mg2+/Ca2+, deglycosylation was primarily observed. 
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Several instances DNA-catalyzed depyrimidination further highlight the catalytic 
competence of DNA. 
 
2.4 Materials and Methods 
2.4.1 Oligonucleotides and in vitro selections 
 Oligonucleotides were prepared by solid-phase synthesis at Integrated DNA 
Technologies (Coralville, IA) and purified by denaturing 20% or 8% PAGE. To avoid 
unwanted chelation of Zn2+ or lanthanide ions by adventitious EDTA, all substrates used 
in kinetic assays were extracted from gels using TN buffer (10 mM Tris, pH 8.0, 300 mM 
NaCl) lacking EDTA and precipitated with ethanol. The DNA substrate sequences during 
the selection process were 5′-CTACCTTTATGCGTATCGAAGGAGGCTTTCGgga-3′, 
where the 3′-terminal gga residues were RNA rather than DNA to enable ligation of the 
substrate to the deoxyribozyme pool strand by T4 RNA ligase during each selection round. 
The DNA substrate sequences used for cleavage assays were the same as those used during 
selection, except the 3′-terminal –Ggga was replaced with –GGGA (i.e., all DNA). The 
deoxyribozyme pool strand during selections was 5′-CGAACGAAAGCCTCCTTC-N40-
ATACGCATAAAGGTAGAGCTGATCCTGATGG-3′, where the two underlined regions 
denote the substrate binding arms. The 5′-CGAA was replaced with 5′-CC for individual 
deoxyribozymes prepared by solid-phase synthesis and used in the single-turnover in trans 
assays. The two PCR primers used during selection were 
5′-CGAACGAAAGCCTCCTTC-3′ (5′-phosphorylated to allow ligation of the product by 
T4 RNA ligase) and 5′-(AAC)4XCCATCAGGATCAGCT-3′ (where X denotes Glen 
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Spacer 18, which is a PEG spacer that stops extension by Taq polymerase and leads to a 
size difference between the two PCR product strands). 
 The selection experiments were performed using 200 pmol (~1014 molecules) of 
DNA in each initial round of selection, where sequence space encompasses 440 ≈ 1024 
possibilities (10–10 sampling of sequence space). During the key DNA hydrolysis step of 
each selection round, the sample was incubated at 37 °C for 12 h. Samples that included 
Zn2+ and a lanthanide ion contained 70 mM HEPES, pH 7.5, 1 mM ZnCl2, 10 µM LnCl3 
and 150 mM NaCl, where Ln = Ce, Eu, or Yb, in the form of CeCl3•7H2O (Aldrich 99.9%), 
EuCl3•6H2O (Acros 99.99%), or YbCl3•6H2O (GFS 99.99%). Lanthanide ion stocks were 
100 mM LnCl3 and 200 mM HNO3, diluted with H2O to 5 × relative to the final desired 
concentration (due to the low final lanthanide ion concentration, the small amount of HNO3 
contributed to the final sample was negligible relative to the much higher HEPES buffer 
concentration). Samples that included Zn2+ either alone or with Mg2+/Ca2+ contained 
70 mM HEPES, pH 7.5, 1 mM ZnCl2, 40 mM MgCl2 or CaCl2 if appropriate and 150 mM 
NaCl. The Zn2+ was added from a 10 × stock of 10 mM ZnCl2 in 20 mM HNO3 and 200 mM 
HEPES, pH 7.5, this 10 × stock was itself prepared from a solution of 100 mM ZnCl2 in 
200 mM HNO3 and a solution of 1 M HEPES, pH 7.5.
32 Samples that included Mn2+ 
contained 50 mM HEPES, pH 7.5, 20 mM MnCl2 and 150 mM NaCl. 
 Cloning and initial screening of individual deoxyribozyme clones was performed 
using DNA strands prepared by PCR from miniprep DNA derived from individual E. coli 
colonies. The miniprep DNA samples were ﬁrst assayed by digestion with EcoRI to 
ascertain the presence of the expected insert. The concentration of each PAGE-puriﬁed 
deoxyribozyme strand was estimated from the intensity (UV shadowing) relative to 
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suitable standards. Each screening assay used ~ 0.1 pmol of 5ʹ-32P-radiolabeled L substrate 
and 2 pmol of the deoxyribozyme strand. 
 
2.4.2 DNA cleavage assay procedures 
 The DNA cleavage assays using individual deoxyribozymes were performed under 
single-turnover in trans conditions using a DNA substrate with sequence 
5′-CTACCTTTATGCGTATCGAAGGAGGCTTTCGGGA-3′ (i.e. all-DNA sequence 
version of the substrate used during the selection experiments). The 5ʹ-32P-radiolabeled 
substrate (S) was the limiting reagent relative to the deoxyribozyme (E). A sample 
containing 0.2 pmol of S and 20 pmol of E was annealed in 5 mM HEPES, pH 7.5 (or other 
buffer as appropriate), 15 mM NaCl and 0.1 mM EDTA (EDTA was omitted in all assays 
with lanthanides) by heating at 95 °C for 3 min, cooling on ice for 5 min and heating at 
37 °C for 2 min. The cleavage reaction was initiated using the same method as for 
selections described in the previous section. Final concentrations for all single-turnover 
experiments were 10 nM S and 1 μM E in 10-25 L total volume. The metal ion stocks 
were added last to the final sample, which was divided into 2 μL aliquots that were all 
incubated at 37 °C. At appropriate times, aliquots were quenched with 5 μL of stop solution 
[80% formamide, TBE (89 mM each Tris and boric acid and 2 mM EDTA, pH 8.3), 50 mM 
EDTA, 0.025% bromophenol blue, 0.025% xylene cyanol]. Samples were separated by 
20% PAGE and quantified with a PhosphorImager. The final incubation conditions were 
as described above for the selection experiments. The lanthanide ion concentration was 3 
to 80 µM. When only lanthanide ions were present (i.e., Zn2+ was absent), the HEPES 
73 
 
concentration was 50 mM. Assay samples were separated by 20% PAGE and quantified 
with a PhosphorImager. Values of kobs and final yield were obtained by fitting the data 
directly to first-order kinetics, i.e., 
yield = 𝑌(1 − 𝑒−𝑘𝑡), 
where k = kobs and Y = final yield. When kobs was sufficiently low such that an exponential 
fit was not meaningful, the initial points were fit to a straight line and kobs was taken as the 
slope of the line. 
 On each assay gel was loaded the same series of oligonucleotide standards. These 
standards provide a common reference point for comparing gel images and also provided 
a basis for preliminary assignment of reaction products, albeit with some ambiguity due to 
near-coincident migration of (i) oligonucleotides of length n with 3′-hydroxyl and 
(ii) oligonucleotides of length n+1 with 3′-phosphate (greater mass reduces the migration 
rate, whereas greater charge increases the migration rate). Because each standard 
oligonucleotide was synthesized with 3′-hydroxyl rather than 3′-phosphate, there is a 
vertical offset for each 3′-phosphate product relative to the corresponding 3′-hydroxyl 
standard band (the product migrates faster than the standard). The definitive assignment of 
each deoxyribozyme’s reaction product was made on the basis of the mass spectrometry 
data. 
 
2.4.3 Mass spectrometry 
 Samples for mass spectrometry were prepared as follows. A 100 µL sample 
containing 60 pmol of substrate and 200 pmol of deoxyribozyme was annealed in 5 mM 
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HEPES, pH 7.5, 15 mM NaCl and 0.1 mM EDTA (the EDTA was omitted for lanthanide-
containing reactions) by heating at 95 °C for 3 min and cooling on ice for 5 min. The 
cleavage reaction was initiated by addition of stock solutions to a final volume of 200 µL 
containing HEPES, pH 7.5 and metal ions as described above for in vitro selection. The 
sample was incubated at 37 °C for 16 h. The nucleic acids were precipitated by adding 
20 µL of 3 M NaCl and 660 µL of ethanol and dissolved in 40 µL water. The sample was 
desalted in 10 µL portions using four C18 ZipTips and analyzed by MALDI mass 
spectrometry with 3-hydroxypicolinic acid as matrix. All MALDI mass spectra were 
obtained in the mass spectrometry laboratory of the UIUC School of Chemical Sciences. 
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Chapter 3: Efforts to Identify Novel DNA Aptamers of ATP 
3.1 Introduction 
 The term “aptamer” is derived from the Latin word aptus (to fit) and from the Greek 
word meros (part).1 Single-stranded DNA and RNA sequences that bind small molecules 
are called aptamers. These functional nucleic acids existed in nature since the early stages 
of evolution of life on Earth. For example, a self-cleaving ribozyme described in Chapter 
1 of this thesis specifically binds a free molecule of GTP, a necessary cofactor for its intron-
splicing mechanism. Riboswitches, also discussed in this thesis, possess an integral 
aptamer region, which upon binding its ligand, either inhibits or activates gene expression 
inside a cell. According to the RNA World hypothesis, nucleic acid aptamers (in addition 
to other functional nucleic acids) played a far greater role a billion years ago than in today’s 
protein-based life. And although the binding (also, catalytic) functions  in nature have 
mostly been replaced by polypeptides, the underlying principle of specific sequence-
dependent nucleic acid interactions with molecular targets still holds true. 
 In 1990, two laboratories independently identified artificial RNA aptamers.1,2 The 
Szostak lab from the Massachusetts General Hospital generated this kind of binders for 
numerous organic dyes and coined the term “in vitro selection”; the Gold lab from the 
University of Colorado identified RNA aptamers for T4 DNA polymerase, giving the name 
SELEX for the process of selection. The letter “L” in this acronym stands for “ligand” and 
this term should be applied specifically to artificial evolution of nucleic acid binders, not 
catalysts.3 The SELEX process is similar to the previously described method of artificial 
evolution to obtain novel ribozymes (for RNA) and deoxyribozymes (for DNA). It is a 
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matter of personal preference which nucleic acid to use in SELEX; however, both DNA 
versions of RNA aptamers and RNA versions of DNA aptamers are inactive.4 Synthesis of 
the random sequence pool and its general design with the variable segment flanked by 
constant primer-binding regions and amplification by PCR is identical for both processes. 
Instead of incubation with substrates, during the key selection step of the SELEX process 
nucleic acid sequences are exposed to molecular targets that are covalently attached to a 
solid-phase support (e.g., agarose beads). Incubation conditions for this step must be 
chosen carefully, often with regard to likely future use for possible aptamers in mind. 
Variables include buffer identity and pH, temperature and the time of incubation as well as 
metal ions and their concentrations. Sequences with high affinity towards this molecular 
target bind the small molecule and become immobilized while the rest of the sequences are 
eluted out and discarded. Single-stranded nucleic acid sequences from the pool bound to 
the immobilized targets undergo another incubation under the same conditions but in the 
presence of free target molecules. For more stringent selections, the concentration of free 
target molecules should be decreased in later rounds. Sequences that switch from binding 
immobilized targets to binding free targets can then be eluted and amplified. In other cases, 
free targets are not used. Instead, the mixture is incubated with denaturing or chelating 
agents to break interactions between DNA and immobilized target molecules. After the 
sequence pool becomes enriched with binders of desired affinity, individual sequences are 
cloned and studied to determine parameters such as binding constants. Aptamers for large 
molecules (specifically, proteins) can be identified via the routes described above. In 
addition to these methods, proteins with net positive charge (which is true of most proteins) 
can be separated on filters made of nitrocellulose, which are negatively charged. 
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 Aptamers have found numerous uses in today’s biomedical and biotechnological 
industries. They are applied in food safety applications, as biosensors for molecular 
diagnostics, as drug delivery agents or as probes for flow cytometry.5-8 In this work we are 
interested in the modular incorporation of a DNA aptamer sequence into a deoxyribozyme. 
This work is described in Chapter 4 of this thesis. 
 Examples of some of the best-characterized aptamers include RNA and DNA 
aptamers that were selected to bind ATP (adenosine triphosphate) molecules, first 
published by the Szostak lab in 1993 and 1995, respectively.9,10 Due to our laboratory’s 
interest in functional DNA (rather than RNA) molecules, the DNA aptamer of ATP was of 
interest for this work. It was identified from a N72 random sequence pool and in follow-up 
experiments, a 27-nucleotide motif was shown to be responsible for binding two ATP 
molecules.10 Via the method of equilibrium filtration, this aptamer was found to bind 
adenosine with an estimated Kd of about 6 ± 3 M. Extensive mutagenesis studies were 
also performed on the aptamer sequence to identify key nucleotides involved in the binding 
of free ATP molecules. Additionally, numerous analogs of ATP were used to determine 
specificity of the target–aptamer interaction. These experiments led to an accurate view of 
the structure that these sequences adapt when ATP molecules are bound. The results were 
later confirmed by NMR studies of the complexes in solution.11 
 Encouraged by the ability to discover aptamers via SELEX and, specifically, DNA 
aptamers of ATP by other scientists,10,12 we chose to identify and characterize new ATP 
aptamers followed by their modular incorporation into the design of deoxyribozyme 
selections. We also planned to use the Szostak ATP aptamer in these future selection 
experiments either alongside the newly identified aptamers or as the sole aptamer motif in 
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the case of failing to find ATP aptamers in this effort. Because ATP molecules serve as 
substrates for countless biochemical reactions, we envisioned incorporating an invariable 
ATP aptamer sequence near the randomized region of the DNA pool for in vitro selections 
of DNA catalysts. In all deoxyribozymes, the formerly random regions are required both 
to catalyze a reaction and to bind substrates. An incorporated aptamer module specifically 
responsible for binding a small molecule would position it in the vicinity of the random 
region, providing it with an easy access to the substrate. This approach could lead to the 
discovery of faster, more numerous deoxyribozymes as the random region would only be 
tasked with catalysis, but not with substrate binding. 
 
3.2 Results and Discussion 
3.2.1 Design and implementation of ATP DNA aptamer selections 
 ATP molecules immobilized on agarose beads through the -phosphate were used 
in this work (Fig. 3.1). The Szostak ATP aptamer was identified with ATP linked through 
the C8 atom. 
 
Figure 3.1: ATP molecule 
immobilized on an agarose bead 
used for aptamer selections. 
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 Incubations of radiolabeled random pool DNA sequences were performed inside 
plastic tubes while being nutated to achieve thorough mixing with agarose beads. To elute 
DNA, the entire mixture was transferred into a column filter (permeable to large DNA 
molecules but not to much larger agarose beads) and centrifuged. Sequences that did not 
associate with the beads were collected in the flowthrough. Due to radiolabeling, the 
amount of single-stranded DNA collected in each round was measured with a scintillation 
counter. 
Single-stranded random pool DNA sequences were incubated with underivatized 
agarose beads prior to exposing these molecules to the beads with immobilized ATP. This 
step was very important because some DNA sequences can associate with the solid support 
itself; these DNA molecules were removed in this step. If this was not done, then such 
sequences could have outnumbered target-binding DNA molecules and subverted the 
selection process. 
 A total of eight selection experiments were initiated, exploring three binary 
variables (Table 3.1). First, two random pools were designed in a fashion similar to that 
described in Chapter 2, with the variable region consisting of 30 nucleotides (N30). One of 
the two pools also included four-nucleotide complementary sequences immediately 
flanking the random region (B, D, F, H selections). The two primer-binding portions were 
on the either side of this region. The second pool did not include the additional pairs of 
nucleotides and its total length was shorter by eight nucleotides (A, C, E, G selections). 
Random pool designs are presented in Fig. 3.2. How the ATP-bound sequences were eluted 
constituted the second variable: either free ATP or EDTA (ethylenediaminetetraacetic 
acid) was used to aid in removal of DNA from solid support. A, B, E and F selections were 
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eluted with ATP, while C, D, G and H selections were eluted with EDTA. When a sequence 
dissociates from its target on an agarose bead and binds a free ATP molecule in solution, 
it can be eluted. EDTA chelates metal ions which are necessary for aptamer structures; 
removing metal ions would also lead to single-stranded DNA dissociation from agarose-
bound ATP. Finally, as the third variable, incubations were performed under two 
conditions: 40 mM Mg2+ with 50 mM CHES, pH 9.0 or 40 mM Mg2+, 20 mM Mn2+ with 
50 mM HEPES, pH 7.5; all incubations were done with 150 mM NaCl at room temperature. 
 A B C D E F G H 
Pool N30 N30 + 4 b.p. N30 N30 + 4 b.p. N30 N30 + 4 b.p. N30 N30 + 4 b.p. 
Elution ATP EDTA ATP EDTA 
Metals Mg2+ + Mn2+ Mg2+ 
Table 3.1: Letter designation of each aptamer selection experiment and its corresponding 
random pool design, whether ATP-binding sequences were eluted with ATP or EDTA and the 
metals used during incubation (50 mM HEPES, pH 7.5 for Mg2+ + Mn2+ and 50 mM CHES, 
pH 9.0 for Mn2+ both with 150 mM NaCl). 
 
 
 Each of the eight aptamer selections was iterated for ten rounds. Percentage of 
single-stranded DNA sequences (eluted with either free ATP or with EDTA) relative to the 
Figure 3.2: Design of the random sequence DNA pools for the ATP aptamer selection 
experiments. The N30 random region was either (A) directly connected to the primer-binding 
arms in the pool for the A, C, E and G selections or (B) connected via four base-paired 
nucleotides in the pool for the B, D, F and H selections. 
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entire amount of pool molecules eluted is reported in Fig. 3.3. Unlike in the previous 
selections of DNA catalysts, high backgrounds are observed in activity values for aptamer 
selections. Only the values above 10-15%, which also increased in the following round, 
were considered to be real representations of the pool’s enrichment with single-stranded 
ATP binders. The activity of the C selection increased above the background range to over 
20% by rounds 7 and 8 (Fig. 3.3). At round 9, all four selections that were incubated in 
presence of both Mg2+ and Mn2+ had activities at or above 30%, and individual sequences 
from these pools were cloned. Even after ten rounds, none of the four selections incubated 
with Mg2+ as the sole polyvalent metal ion had consistent activities above the 10-15% 
background level, and their progress was terminated. 
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Figure 3.3: Progression of the A-H ATP aptamer selection experiments. For each selection, 
the round at which individual DNA sequences were cloned is marked with an arrow on the 
plot. 
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3.2.2 Characterization of the aptamer candidate sequences 
 The A, B, C and D ATP aptamer selections were cloned at round 9 and eight E. coli 
colonies were chosen for each selection. Each set of the colonies contained three unique 
sequences for each of the four pools (Fig. 3.4). All sequences from the B and D selections 
retained the additional nucleotides flanking the random region although these were not 
parts of the primer-binding sites and were subject to potential mutations during PCR 
amplification. Formerly random region lengths also did not change and remained 30 
nucleotides long. No regions of conservation among the twelve sequences were observed 
in the sequence alignment. 
 
 All twelve aptamer candidate sequences were prepared via solid-phase synthesis 
for quantitative assessment of their interaction with ATP. All oligonucleotides were 
synthesized without 5ʹ-binding arms since these regions were not designed to be present 
Figure 3.4: Sequences of the initially random (N30) regions of the A-D ATP aptamer 
selections. All residues identical to those of 9A1 in the corresponding position are 
depicted as dots. 
87 
 
after modular incorporation of aptamer sequences into random pools for DNA catalyst 
selections. Three methods of ATP binding characterization were employed. First to be tried 
were bead binding assays in which each sequence was eluted with ATP at increasing 
concentrations. Next, DMS (dimethyl sulfate) probing experiments were performed. This 
method is a well-known way to locate the regions of DNA that interact with proteins and 
other molecules and may also be used to estimate binding strengths.13 Finally, these 
aptamer candidate sequences were assayed by equilibrium filtration in which DNA is 
incubated with free target molecules.14 Then the mixture is separated on centrifugal filter 
columns permeable to small ATP molecules but not to large single-stranded DNA. In all 
three methods, the twelve new sequences were assayed along with two well-characterized 
ATP aptamers. The first of the two previously known aptamers was already described in 
section 3.1; it was identified by David Huizenga and Jack Szostak and is  referred to as the 
DH aptamer.10 The second aptamer is a modification of the first one that binds one ATP 
molecule instead of two. It is 37 nucleotides in length (10 longer than the DH aptamer) and 
was identified by Mihaela Barbu and Milan Stojanovic in 2012. This aptamer is referred 
to as the MB aptamer.12 
 In bead binding assays, each oligonucleotide was incubated with ATP-derivatized 
agarose beads and then eluted with free ATP molecules. The elution was done in several 
steps, each with an increasing concentration of ATP: 30 nM, 100 nM, 300 nM, 1 M, 3 M, 
10 M, 30 M, and finally 100 M. The total amount of eluted DNA during each 
88 
 
successive step was added to the previous amount and plotted to fit the binding curves 
using the following equation: 
𝑌 = 100 ∙
𝐶𝑛
𝐶𝑛 + 𝐾𝑑
𝑛 
where Y = % of DNA eluted, C = concentration of ATP and n is the Hill coefficient for 
ATP binding. Previous studies established that two molecules of ATP bind to the DH 
aptamer and one molecule of ATP binds to the MB aptamer; therefore, n = 2 and n = 1 
values were used for their respective fits. We hypothesized that only one ATP molecule 
binds to each of the twelve aptamer candidate sequences, so n = 1 was used for these fits. 
The plots for the two previously identified ATP aptamers (used as controls for this assay) 
as well as the three 9D aptamer candidate sequences (representative of all twelve aptamer 
candidates from the A-D aptamer selections) are shown in Fig. 3.5. 
 
Figure 3.5: Bead-binding assays of 9D1, 9D3 and 9D4 ATP aptamer candidates as well as 
DH and MB ATP aptamers. Relative amount of radiolabeled sequences eluted with each 
successive ATP concentration (30 nM to 100 M) as percent of the total DNA eluted with 
ATP is plotted. 
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While the plots fit to an S-shaped curve, reliable aptamer binding data could not be 
derived from the fits because only as little as 10% of the total amount of sequences eluted 
with free ATP. The rest of the sequences either remained bound to the beads or were 
removed when the filters were washed with buffer solutions prior to addition of free ATP, 
as detected by scintillation counting. Furthermore, bead binding assays do not represent a 
simple system as both free and immobilized target molecules as well as free and bound 
(either to an immobilized or a free target) aptamers are present in the mixture. Therefore, 
we chose to discontinue testing the aptamers by bead binding. 
 Next, to characterize ATP binding of the twelve aptamer candidates, we turned to 
DMS probing. These assays are usually used for nucleic acid secondary structure 
determination, however sometimes they are employed to characterize binding affinities of 
aptamers and their targets. DMS methylates accessible guanine nucleobases at the N7 
position. If a particular guanine of an aptmer candidate is actively interacting with ATP 
such that its N7 position is blocked, it is not methylated by DMS. The methylated 
nucleobases are then deglycosylated specifically by piperidine. This glycosidic bond 
cleavage eventually leads to single-stranded DNA strand scission after two spontaneous 
-elimination reactions. After 5ʹ-radiolabeled DNA is treated with DMS followed by 
piperidine, it is resolved on PAGE as cleavage product strands of different lengths migrate 
at different rates. Because each cleavage event is the result of a G nucleobase methylation, 
each accessible guanine can be accounted for by locating the corresponding band on the 
gel. Any G nucleobases directly involved in ATP binding will not be methylated and a 
band corresponding to strand cleavage next to these nucleobases will not appear on the gel. 
At low ATP concentrations, most binding sites in an aptamer are not occupied and all 
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guanines are accessible for methylation, resulting in the observation of all possible 
corresponding bands on the gel. At ATP concentrations several-fold higher than the Kd 
value of an aptamer, such G nucleobases are not methylated and the corresponding bands 
disappear from the gel. 
 No previously published DMS probing data for either of the two control aptamers 
was available. At sufficiently high ATP concentrations, we expected to observe a pattern 
on PAGE corresponding to no N7 methylation of guanines involved in ATP binding. 
However, every guanine was observed to be methylated by DMS even at high ATP 
concentrations, as evidenced by the presence of the corresponding bands on PAGE at all 
concentrations of ATP tested (Fig. 3.6). Nevertheless, the binding propensity of these two 
aptamers has been well established, which means that DMS probing simply cannot reveal 
their interactions with the ATP targets. None of the twelve aptamer candidate sequences 
exhibited the pattern suggestive of guanine methylation (Fig. 3.6). This finding does not 
clearly repudiate that all 14 sequences tested are incapable of binding ATP at 
concentrations tested, as it may be entirely possible for all guanines in an aptamer bound 
to ATP to be accessible for methylation by DMS. 
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Because we were unable to characterize ATP binding of the twelve aptamer 
candidates in addition to the two known aptamers by both bead binding assays and DMS 
probing, we turned to the method of equilibrium filtration. In this technique, filters 
permeable to small molecules but not to long DNA strands are used. DNA aptamer 
sequences prevent bound ATP molecules from moving across the filter membrane when 
the filters are centrifuged. In presence of a DNA aptamer at a sufficient level, ATP 
concentration in the filtrate should be lower than in the solution prior to centrifugation. 
Figure 3.6: PAGE of DMS probing assays of 9D3 ATP aptamer candidate (similar data was 
observed for the rest of the aptamer candidates, not shown) as well as DH and MB ATP 
aptamers. ATP concentrations were 0, 1 nM, 10 nM, 100 nM, 1 M, 10 M and 100 M. The 
more distinct bands represent guanines accessible for methylation by DMS. Positions of 
G nucleotides in these sequences (presented in the Materials and Methods section) can be 
confirmed on the gels in a fashion similar to the Sanger sequencing method. 
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To characterize target-aptamer interactions of the twelve aptamer candidates and 
the two known ATP aptamers, the ATP concentration was kept constant at 30 M while 
the concentration of DNA was varied in the range of 100 nM-100 M. Trace amounts of 
radioactive -32P-ATP were also added to each sample to measure target concentrations 
across the membrane (in both filtrate and retentate). Presence of DNA aptamers at high 
concentrations was expected to lead to appreciable retention of ATP molecules in the 
retentate solution resulting in a lower number of counts in the filtrate solution. A sample 
containing a 27-nucleotide sequence incapable of binding ATP was used as reference to 
compare ATP concentrations in the filtrate. All twelve aptamer candidates and both known 
ATP aptamers were characterized under (parental) conditions used during selections that 
led to their identification. Buffer identity, pH and metal ion concentrations used to identify 
the known ATP aptamers were slightly different than those used in the A-D selections). 
Even at 100 M DNA concentration, significant retention of ATP was not observed for 
any of the twelve aptamer candidates. However, when each known ATP aptamer was 
present at 10-100 M, ATP concentration in the filtrate was significantly reduced, 
indicating successful binding of ATP by the two aptamers, albeit with values of Kd 
estimated to be several-fold higher than previously reported (Fig. 3.7). For true binding 
constant measurements, equilibrium filtration assays with even higher but cost-prohibitive 
aptamer concentrations were not performed. The discrepancy between our estimated Kd 
values and those previously reported may be due to the method of characterization. In 
addition to being evaluated under parental (20 mM Tris, pH 7.6, 5 mM Mg2+, 300 mM 
NaCl) conditions, target binding of the two known ATP aptamers was also characterized 
under the conditions (50 mM HEPES, pH 7.5, 40 mM Mg2+ + 20 mM Mn2+, 150 mM NaCl 
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and 50 mM CHES, pH 9.0, 40 mM Mg2+, 150 mM NaCl) planned to be used during 
deoxyribozyme selections with DNA aptamer modules (Figure 3.7). Under the new 
conditions, both ATP aptamers exhibited levels of ATP binding similar to those under 
parental conditions. Therefore, due to our inability to identify new ATP binders, we 
decided to integrate only the previously reported ATP aptamers into the pools for modular 
selections of DNA enzymes. This work is described in Chapter 4. 
 
3.3 Summary 
 In this chapter, we attempted to identify single-stranded DNA sequences that 
specifically bind ATP starting from two pools of random sequences via the in vitro 
selection process. ATP-derivatized agarose beads were used to separate sequences capable 
of binding targets from the rest of the pool population. Then these sequences were eluted 
Figure 3.7: Equilibrium filtration assays with 30 M ATP and 5–100 M DH (A) or MB (B) 
aptamer with three different salt/pH conditions. Amount of radioactivity in 20 L of each 
filtrate and retentate was measured by scintillation counting and divided by the number of 
counts in the respective fractions of the reference sample to get the value for the % of 
reference. This value was directly proportional to ATP concentration due to the presence of 
radiolabeled ATP molecules in trace amount in each sample. 
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with either free ATP molecules or with metal-chelating EDTA that interferes with nucleic 
acid secondary structures, causing dissociation of aptamers from immobilized targets. 
Selection experiments that were performed with both Mg2+ and Mn2+ (but not those with 
Mg2+ alone) resulted in domination of pools by sequences that presumably bound to 
immobilized ATP. 
 After subsequent cloning and sequencing of twelve individual members of the 
active pool populations, several attempts to characterize their ATP interactions were made. 
In addition to aptamer candidates that emerged from these selection experiments, two 
previously published DNA aptamers for ATP were characterized by the same methods. 
Assays in which DNA sequences were exposed to agarose-bound ATP molecules and then 
eluted with increasing concentrations of free ATP did not provide strong evidence of target 
concentration-specific elution of DNA. This was especially apparent when the two 
previously published and well-characterized ATP aptamers exhibited the same non-
specific elution behavior. Next, aptamer-target complexes were probed with DMS, a 
molecule that preferably methylates guanine nucleobases at the N7 position when they are 
not sterically hindered by interactions with bound ATP Unfortunately, all guanine 
nucleobases were methylated in both previously published ATP aptamers as well as all 
twelve aptamer candidates. This outcome, however, could not repudiate the binding nature 
of a DNA sequence and its target, but simply indicated the absence of guanine methylation 
sites involved in interactions with ATP, at least for the two previously published aptamers. 
Finally, ATP binding by the two previously published DNA aptamers was confirmed via 
the method of equilibrium filtration. The same approach did not reveal any evidence of 
ATP binding by any of the twelve aptamer candidates that emerged from the selection 
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experiments. Therefore, all twelve aptamer candidates were set aside in favor of the two 
well-characterized DNA aptamers of ATP to be used in future selection experiments with 
aptamer modules. 
 
3.4 Materials and Methods 
3.4.1 Oligonucleotides and in vitro selection of ATP-binding DNA 
aptamers 
 The two random DNA pool sequences used in these selection experiments were 
5ʹ-CGAAGCGCTAGAACAT-N30-AGCTGATCCTGATGG-3ʹ (without the extra stem 
loop) and 5ʹ-CGAAGCGCTAGAACATGCCG-N30-CGGCCAGCTGATCCTGATGG-3ʹ 
(with the extra four base-pair stem loop). They were synthesized on the ABI 394 
DNA/RNA oligonucleotide synthesizer. All other sequences were prepared by solid-phase 
synthesis at Integrated DNA Technologies (Coralville, IA). All oligonucleotides were 
purified by denaturing 20% or 8% PAGE. 
 All reactions were performed at room temperature. Centrifugations were performed 
for 1 min at 1000 RCF (Relative Centrifugal Force) with 5494 model Eppendorf centrifuge 
in Micro Bio-spin chromatography columns (Bio-Rad). Incubations of DNA with agarose 
beads were done inside 2.0 mL low retention microcentrifuge tubes (Fisher) on the nutator 
(Fisher 260100F). Scintillation counter model used was Beckman LS6500. 
 10 L of underivatized agarose beads were washed with 5×250 L of selection 
buffer (150 mM NaCl and 40 mM MgCl2 with 50 mM Tris, pH 9.0 or 40 mM MgCl2 + 
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20 mM MnCl2 with 50 mM HEPES, pH 7.5) inside a Micro Bio-spin chromatography 
column (Bio-Rad) for 1 min and centrifuged. Then the filtrate was discarded. 
Heat-denatured (95° C for 5 min, on ice for 10 min) selection pool (1 pmol of 5ʹ-
radiolabelled pool:199 pmol non-radiolabeled pool for round 1 or radiolabeled PCR 
product for rounds 2+) dissolved in 400 L of selection buffer was mixed with 20 pmol of 
blocking oligonucleotide 5ʹ-(AAC)20-3ʹ and the washed underivatized agarose beads inside 
a microcentrifuge tube and incubated at room temperature on a nutator for 30 min. The 
mixture was then transferred to a spin column and centrifuged. The beads were washed 
with 2×200 L selection buffer and the flowthrough fractions combined. The underivatized 
agarose beads were mixed with water and retained for scintillation counting. 
The ATP-derivatized agarose beads were obtained from Jena Biosciences, Inc 
(Jena, Germany), catalog number AC-101 [(ATP - Immobilized γ-Aminophenyl-ATP 
(C10-spacer)], 20 mol/mL ATP concentration. In every selection round, 300 nmol of 
immobilized ATP were washed with 10×250 L of selection buffer, then the mixture was 
centrifuged and the resulting filtrate discarded. 20 pmol of the blocking oligonucleotide 
was mixed with the washed ATP-derivatized beads and 400 L of selection buffer. The 
mixture was incubated on the nutator inside an Eppendorf tube and then transferred to the 
spin column and centrifuged; the resulting filtrate was discarded. The ATP-derivatized 
beads were then mixed with the flowthrough containing selection pool from the previous 
step (800 L total volume) and incubated on a nutator for 1 h. The mixture was transferred 
to the spin column and centrifuged. The flowthrough was retained for scintillation 
counting. The ATP-derivatized beads together with bound DNA sequences inside the spin 
column were washed with 10×200 L of selection buffer (following addition of the buffer 
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the mixture was incubated for 3 min for a total incubation time of 30 min). Flowthrough 
fractions from every two washes were combined and retained for scintillation counting. 
 To elute ATP-binding DNA sequences, 300 L of ATP elution buffer (20 M ATP, 
150 mM NaCl and 40 mM MgCl2 with 50 mM Tris, pH 9.0 or 40 mM MgCl2 + 20 mM 
MnCl2 with 50 mM HEPES, pH 7.5) was mixed with the washed beads from the previous 
step inside 1.7 mL Eppendorf tube and incubated for 1 h (2 h for round 1) on the nutator. 
After that, this mixture was transferred to the spin column and centrifuged. 1 h incubation 
followed by centrifugation was repeated and the two elution fractions were combined and 
retained for scintillation counting. The spin column was washed with 2×200 L of selection 
buffer, combining the flowthrough fraction for scintillation counting. For selections in 
which DNA sequences were eluted with EDTA, the above ATP elution step was followed 
by two successive 1 h incubations of the ATP-derivatized beads in 300 l of EDTA elution 
buffer (5 mM EDTA, 150 mM NaCl and 40 mM MgCl2 with 50 mM Tris, pH 9.0 or 
40 mM MgCl2 + 20 mM MnCl2 with 50 mM HEPES, pH 7.5) each followed by 
centrifugation and retention of the combined flowthrough fractions. The spin column was 
washed with 2×200 L of selection buffer combining the flowthrough fraction for 
scintillation counting. The underivatized agarose beads were mixed with water and retained 
for scintillation counting. 
DNA sequences eluted with either the ATP elution buffer or the EDTA elution 
buffer were PCR-amplified after removing salts by precipitating DNA with ethanol and 
drying the pellets in a SpeedVac vacuum concentrator. The forward primer, which was 
used to initiate Taq-catalyzed synthesis of a pool molecule, had the sequence 
5ʹ-CGAAGCGCTAGAACAT-3ʹ. The reverse primer, which was used to initiate Taq-
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catalyzed synthesis of the reverse complement of a pool molecule had the sequence 
5ʹ-(AAC)4XCCATCAGGATCAGCT-3ʹ (where X denotes Glen Spacer 18, which is a PEG 
spacer that stops extension by Taq polymerase and leads to a size difference between the 
two PCR product strands). The amplification was performed in a total volume of 100 µL 
for 10 cycles (94 ºC for 30 s, 47 ºC for 30 s, 72 ºC for 30 s) by Taq polymerase with 1 µM 
of forward primer, 0.25 µM of reverse primer and 200 µM of each dATP, dCTP, dGTP 
and dTTP, in addition to a trace amount of -32P-dCTP are added in 30-cycle PCR. Phenol-
chloroform-isoamyl alcohol extraction was performed and ~100 L of the aqueous PCR 
product solution was taken out. 1 µL aliquot of this solution was used as the template for a 
30-cycle PCR in a total volume of 50 µL. The PCR product was purified by 8% PAGE. 
The shorter PCR product was excised, extracted, precipitated by ethanol and used for the 
next round of aptamer selection with ATP-derivatized agarose beads. 
 
3.4.2 Cloning of individual sequences 
The selection process led to a pool enriched with ATP-binding DNA molecules. 
These DNA sequences had same number of nucleotides (approximately same molecular 
weight) but differed in their nucleotide compositions. In order to obtain sequences of 
individual ATP aptamer candidates, molecular cloning was performed.  
The pool synthesized in the 10-cycle PCR step of the selection round of interest 
was used as a PCR template to generate double-stranded DNA for cloning. This PCR 
product was purified on 2% agarose gel and inserted into a TOPO vector containing an 
ampicillin resistance gene (Invitrogen). Competent E. coli cells were transformed with 
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these plasmids. These cells were spread on a cell culture media plate containing ampicillin 
and the plate was incubated at 37oC for 14-16 h. During this time, cells divided, forming 
either white colonies, in which the double-stranded DNA PCR product was inserted into 
the vector, or blue colonies, in which the vector did not include double-stranded PCR 
product. White colonies were picked from these plates and grown at 37oC for 18 h in culture 
media containing 50 g/mL ampicillin. 
Every white colony was generated from a cell containing a plasmid that 
corresponded to one particular aptamer candidate sequence. During the cloning procedure, 
individual DNA sequences were amplified inside E. coli. The DNA from these cells was 
extracted using miniprep kits (Thermo Fisher) and the proper insert size was verified by 
plasmid digestion with EcoRI. Sequence compositions of individual aptamer candidates 
were provided by the Core Sequencing Facility at the University of Illinois. 
 
3.4.3 Testing of aptamer candidate sequences by bead binding 
 Bead-binding assays were performed essentially as described for the aptamer 
selection experiments, up to and including the 1 h incubation of DNA sequences with ATP-
derivatized agarose. Next, washes with 10×100 L of selection buffer were performed, and 
all flowthrough fractions were retained. After that, seven 30 min incubations followed by 
elutions via centrifugation were done. Each elution buffer was prepared similarly to that 
for aptamer selections except free ATP was present in each wash at an increasing 
concentration (30 nM, 100 nM, 300 nM, 1 M, 3 M, 10 M, 30 M and 100 M). Eluted 
solutions from each wash in addition to the agarose beads were retained for scintillation 
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counting. Each aptamer candidate’s DNA molecule was 5ʹ-radiolabeled with -32P-ATP by 
PNK and used in trace amount together with 50 pmol of unlabeled DNA. 
 
3.4.4 DMS probing assays 
 0.2 pmol of 5ʹ-radiolabeled aptamer candidate dissolved in 9 L selection buffer 
was incubated at room temperature for 30 min. An 11 L aliquot of ATP dissolved in 
selection buffer was added for a final ATP concentration of 1 nM, 10 nM, 100 nM, 1 M, 
10 M or 100 M. A control reaction with no ATP was also performed. All samples were 
incubated at room temperature for 1 h. Methylation of DNA was initiated by adding 
2.25 L of freshly prepared aqueous 1.2% DMS to each sample. After 30 min incubation, 
DNA was precipitated with ethanol and the dried pellet was dissolved in 50 L of 
10% piperidine. The mixture was heated for 30 min at 90°C followed by cooling on ice for 
30 min after which the samples were dried in the SpeedVac. Each sample was resolved on 
PAGE and exposed to a Phosphoimager screen. 
 Sequences of the oligonucleotides used in DMS probing assays shown in Fig. 3.7 
were: 
9D3: 5ʹ-GCCGACCCCAGGACCAAAGTTCGACAGAGCGAGACGGCCAGCTGATC 
  CTGATGG-3ʹ, 
DH: 5ʹ-ACCTGGGGGAGTATTGCGGAGGAAGGT-3ʹ, 
MB: 5ʹ-CCACTGAGGGGCGAGGAGCAGAAACTGCGGGGAGTGG-3ʹ. 
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3.4.5 Equilibrium filtration assays  
 Each ATP aptamer candidate, DH and MB ATP aptamers as well as (AAC)9 
oligonucleotide reference sample (doesn’t bind ATP) was dissolved in a 200 L solution 
and was incubated in Amicon 3K Ultra centrifugal filters (Millipore) at room temperature 
for 10 min. Each mixture contained 30 M ATP, 2.5 nM -32P-ATP, and DNA at one of 
100 nM, 200 nM, 500 nM, 1 M, 2 M, 5 M, 10 M, 20 M and 100 M concentrations. 
Additionally, three salt/buffer conditions were used: 
i) 5 mM MgCl2, 20 mM Tris, pH 7.6, 300 mM NaCl; 
ii) 40 mM MgCl2, 20 mM MnCl2, 50 mM HEPES, pH 7.5, 150 mM NaCl; 
iii) 40 mM MgCl2, 50 mM CHES, pH 9.0, 150 mM NaCl. 
After incubation, the mixtures were centrifuged in Amicon filters at 8000 RCF for 15 min 
resulting in 40-80 L volume in the filtrate. 20 L volumes of both filtrate and retentate 
fractions from each sample were used for scintillation counting. 
 
3.5 References 
1. Ellington, A. D.; Szostak, J. W., In vitro selection of RNA molecules that bind 
secific ligands. Nature 1990, 346, 818-822. 
2. Tuerk, C.; Gold, L., Systematic evolution of ligands by exponential enrichment: 
RNA ligands to bacteriophage T4 DNA Polymerase. Science 1990, 249, 505-510. 
3. Silverman, S. K., Artificial functional nucleic acids: aptamers, ribozymes and 
deoxyribozymes identified by in vitro selection. In Functional Nucleic Acids for 
102 
 
Analytical Applications, Y. Li and Y. Lu, eds.; Springer Science + Business Media, 
LLC: New York, 2009. 
4. Dieckmann, T.; Butcher, S. E.; Sassanfar, M.; Szostak, J. W.; Feigon, J., Mutant 
ATP-binding RNA aptamers reveal the structural basis for ligand binding. J. Mol. 
Biol. 1997, 273, 467-478. 
5. Meyer, M.; Scheper, T.; Walter, J. G., Aptamers: versatile probes for flow 
cytometry. Appl. Microbiol. Biotechnol. 2013, 97, 7097-7109. 
6. Amaya-Gonzalez, S.; de-los-Santos-Alvarez, N.; Miranda-Ordieres, A. J.; Lobo-
Castanon, M. J., Aptamer-Based Analysis: A Promising Alternative for Food Safety 
Control. Sensors 2013, 13, 16292-16311. 
7. Wang, C.; Liu, B.; Lu, J.; Zhang, G.; Lu, A. P., Strategies for Combination of 
Aptamer and Targeted Drug Delivery. J. Nanosci. Nanotechnol. 2014, 14, 501-512. 
8. Zhou, W. Z.; Huang, P. J. J.; Ding, J. S.; Liu, J., Aptamer-based biosensors for 
biomedical diagnostics. Analyst 2014, 139, 2627-2640. 
9. Sassanfar, M.; Szostak, J. W., An RNA motif that binds ATP. Nature 1993, 364, 
550-553. 
10. Huizenga, D. E.; Szostak, J. W., A DNA aptamer that binds adenosine and ATP. 
Biochemistry 1995, 34, 656-665. 
11. Lin, C. H.; Patel, D. J., Structural basis of DNA folding and recognition in an AMP-
DNA aptamer complex: distinct architectures but common recognition motifs for 
DNA and RNA aptamers complexed to AMP. Chem. Biol. 1997, 4, 817-832. 
12. Barbu, M.; Stojanovic, M. N., A fresh look at adenosine-binding DNA motifs. 
ChemBioChem 2012, 13, 658-660. 
103 
 
13. Baldwin, A. S., Oettinger, M. and Struhl, K. Methylation and Uracil Interference 
Assays for Analysis of Protein-DNA Interactions. Current Protocols in Molecular 
Biology, 36:12.3:12.3.1–12.3.7, 2001. 
14. Kato, T.; Takemura, T.; Yano, K.; Ikebukuro, K.; Karube, I., In vitro selection of 
DNA aptamers which bind to cholic acid. Biochim. Biophys. Acta. 2000, 1493, 12-
18. 
 
104 
 
Chapter 4: Selections of DNA Enzymes with Discrete Catalyst and ATP 
Aptamer Domainsa 
4.1 Introduction 
Nucleic acids, peptides, sugars and other substrates attached to a random DNA pool 
have been used to identify deoxyribozymes by in vitro selection.1-7 DNA-hydrolyzing 
deoxyribozymes, described in Chapter 2, cleave an all-DNA substrate with an external 
water molecule in aqueous solution. In these and similar cases, much of the catalyst-
substrate binding interaction—and therefore the corresponding binding energy—is 
provided by the Watson-Crick base pairing. These straightforwardly preprogrammed 
binding contacts enable the selection process to focus upon finding initially random DNA 
sequences that are tasked primarily with catalysis. However, for small-molecule substrates 
that inherently cannot engage in extensive Watson-Crick interactions, the initially random 
DNA region (e.g., N40) must instead simultaneously bind the substrate and catalyze the 
desired reaction, rather than solely participate in catalysis. DNA-hydrolyzing 
deoxyribozymes, assisted by metal ion cofactors, bind a water molecule (although its 55 M 
concentration does not require substantial binding specificity) and catalyze strand 
cleavage.8 The work described in this chapter was based on an explicitly modular approach 
to deoxyribozyme catalysis, in which a predefined DNA aptamer (binding) domain 
engages in aptamer-like non-Watson-Crick contacts with the small-molecule substrate. 
This could allow identification of a distinct “catalytic” (enzyme) domain from a random 
                                                          
a The material described in this chapter has been published and is used here with permission: 
Dokukin, V.; Silverman, S. K., A Modular Tyrosine Kinase Deoxyribozyme with Discrete 
Aptamer and Catalyst Domains, Chem. Commun. 2014, 50, DOI: 10.1039/c4cc04253k. 
105 
 
DNA region through in vitro selection experiments. Emerging sequences from the initially 
random regions (conjugated to the DNA aptamer module) would be devoted exclusively 
to catalysis. Inclusion of a binding domain adjacent to the random region of a DNA pool 
was hypothesized to aid in finding more numerous and higher-yielding deoxyribozymes 
than via the regular, nonmodular, selection experiments, provided that the DNA enzymes 
make functional use of the aptamer module. 
We chose ATP (adenosine triphosphate) as the small-molecule substrate for this 
work. ATP plays a defining role in biology, serving as a cofactor or a building block in 
numerous cellular processes essential to life. Identification of DNA catalysts capable of 
using ATP as substrates in reactions that are generally catalyzed by protein enzymes (such 
as oligonucleotide phosphorylation or adenylylation) was achieved previously.9,10 
Separately, DNA aptamers that bind ATP with Kd values in the low micromolar ranges 
have also been found.11,12 One particular Mg2+-dependent ATP DNA aptamer domain11 
that has been structurally characterized13 is the basis for a wide range of experiments that 
involve sensors14-29 or other applications.30-33 Here we wished to determine whether 
providing a predefined ATP aptamer module can lead to deoxyribozymes that make 
functional use of this domain during catalysis. There is a natural nucleic acids precedent of 
the modularity phenomenon in that the group I intron ribozyme is modular in binding its 
RNA substrate.34 Of course, many natural protein enzymes are functionally modular.35 
Additionally, we sought to assess whether the availability of the ATP aptamer module 
provides a more robust access by in vitro selection to new deoxyribozymes for chemical 
reactions that require ATP substrates, leading to more numerous or faster DNA catalysts. 
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4.2 Results and Discussion 
4.2.1 In vitro selection of deoxyribozymes for phosphorylation and 
adenylylation of the 5ʹ DNA terminus 
 Our initial efforts focused on identification of DNA catalysts capable of transferring 
either a phosphoryl or an adenylyl functional group to, respectively, the 5ʹ-hydroxyl or the 
5ʹ-phosphate termini of single-stranded DNA. ATP serves as a natural substrate for both of 
these reactions (Fig. 4.1). Phosphorylation of the 5ʹ-OH terminus of DNA is catalyzed by 
Figure 4.1: The two reactivities with ATP for which deoxyribozymes were selected via the 
modular approach: adenylylation (A) and phosphorylation (B). 
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polynucleotide kinases, which are also extensively used in biochemical laboratories that 
study nucleic acids. Nonmodular polynucleotide kinase deoxyribozymes have been 
identified by others.10 To find modular DNA catalysts of this reaction, we started four 
selection experiments with an integrated DNA aptamer domain. 
On the other hand, adenylylation of a 5ʹ-terminal DNA phosphate is the first step 
of the ligation mechanism in which two DNA strands are joined together. This reaction is 
catalyzed in nature by protein ligases. Ligation is an essential laboratory procedure for the 
molecular cloning of DNA. Deoxyribozyme-catalyzed adenylylation of DNA was also 
achieved previously.9 In that work, catalysts were identified via selection experiments from 
N70 random-sequence pools in the absence of an ATP aptamer module. Encouraged by 
these results, we initiated three selection experiments using the modular approach to 
identify DNA-adenylylating DNA enzymes with distinct catalytic and binding domains. 
Because neither 5ʹ-terminal phosphorylation nor adenylylation significantly 
increases charge or mass of a pool molecule linked to the nucleic acid substrate, 
catalytically active sequences cannot be readily separated from inactive ones on PAGE. A 
strategy to capture active sequences was previously developed.9,10 Splint ligation reactions 
(also referred to as the capture reactions) of the 5ʹ-modified DNA molecules with acceptor 
oligonucleotides were employed to achieve separation as the ligation products had higher 
mass and charge than the reactants. T4 DNA ligase enzyme was used to catalyze these 
reactions. To avoid propagation of aberrantly migrating sequences, single-stranded DNA 
capture oligonucleotides of alternating lengths were used in successive selection rounds. 
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5ʹ-Phosphorylation of the donor DNA sequence is required for ligation by the DNA 
ligase enzyme in the presence of ATP. A splint molecule complementary to the ligated 
DNA molecules is also required for this reaction. Only those DNA substrates that acquired 
the 5ʹ-phosphate modification could be ligated, therefore enabling the separation of 
deoxyribozyme kinases from the rest of the random-sequence DNA pool molecules 
(Fig. 4.2A). For adenylylation activity, the splint ligation reactions were performed in 
absence of ATP. The first step of a DNA ligation reaction catalyzed by the DNA ligase 
enzyme is the transfer of the adenylyl group (for which ATP is the donor) to the 
5ʹ-phosphate of DNA. This reaction intermediate readily undergoes the second step of the 
ligation reaction and becomes covalently linked to the 3ʹ-end of the acceptor DNA 
sequence. Because during the selection step, the substrate could be preadenylylated 
(transfer of an adenylyl group to the 5ʹ-phosphate) by catalytically active random-sequence 
DNA pool members, such sequences would be ligated (captured) to the acceptor 
oligonucleotide without the otherwise-required ATP (Fig. 4.2B). However, upon initiation 
of these selection experiments, we realized that the DNA ligase enzyme used for the 
capture step of the selection experiments is provided in the preadenylylated (activated) 
form in the stock tube. This resulted in the capture of sequences that did not undergo the 
required adenylylation, as manifested by observation of ligation products co-migrating 
with the oligonucleotide standards on PAGE in a very early (Round 2) selection rounds. 
When starting with a completely random pool, very rare catalytically active sequences are 
not expected to begin saturating the pool at such an early point. This problem was not 
described in the report of successful discovery of DNA-catalyzed DNA adenylylation,9 
perhaps due to the different vendors from which T4 DNA ligase was purchased (New 
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England Biolabs, from the previous report vs. Fermentas, here). To deactivate the 
preadenylylated DNA ligase molecules, they were incubated with an excess of 
5ʹ-phosphorylated DNA sequences prior to their addition to the pool to catalyze the capture 
step. This strategy was successful, as captured pool sequences were not observed during 
early rounds after the selection was reinitiated. 
 
 
 Three N40 random-sequence DNA pools were synthesized, one of which did not 
include an aptamer module while each of the other two had either the 27-nucleothide DH 
(reported in 1995 by David Huizenga and Jack Szostak11) or the 37-nucleotide MB 
(reported in 2012 by Mihaela Barbu and Milan Stojanovic12) DNA aptamer for ATP. For 
two of the three pools, the aptamer modules were placed immediately at the 3ʹ-end of the 
Figure 4.2: Selections of deoxyribozymes for DNA phosphorylation (A) and DNA 
adenylylation (B). Only the pool without the aptamer region is shown. The acceptor (capture) 
oligonucleotide is provided after the selection step. The capture step is performed in the 
presence of ATP in phosphorylation selections and in the absence of ATP in adenylylation 
selections. 
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random region, flanked on the other side by the invariant primer-binding sequence. The 
third pool lacked the aptamer domain. The set of two primer-binding regions was identical 
for all three pools. The random pool that did not include an ATP aptamer was 73 
nucleotides long while modular incorporation of DH and MB aptamer sequences resulted 
in enlargement of the respective pools to 100 and 110 nucleotides. Due to different pool 
lengths, three sets of oligonucleotide standards (to be resolved on PAGE with selection 
pools) were used after each step of the selection process. A total of seven selection 
experiments were initiated and for all, the key selection reaction was incubated with 1 mM 
ATP for 14 h at 37 °C. With four selection experiments we were seeking to isolate 
polynucleotide kinase deoxyribozymes [one with either MB or no ATP aptamer module 
and two with DH (Mg2+ + Mn2+ and Mg2+ alone) ATP aptamer module-containing random 
pools], while three selections were aimed at identification of DNA-adenylylating DNA 
catalysts (one with each DH, MB and no ATP aptamer module-containing random pool). 
In addition, the incubation mixture included 40 mM MgCl2 and 20 mM MnCl2 with 50 mM 
HEPES, pH 7.5 and 150 mM NaCl (six of seven selections) or 40 mM MgCl2 with 50 mM 
CHES, pH 9.0 and 150 mM NaCl (one of seven selections). Although the DH aptamer was 
identified through incubations at room temperature, extensive studies indicate that its ATP 
binding is at least as strong at the elevated temperature of 37 °C as at room temperature.36,37 
 Each selection was iterated for eight to twelve rounds. All seven selections resulted 
in substantial capture yields (up to 23%). This yield value should be compared to the 
maximum capture yield of prephosphorylated or preadenylylated substrates of 60-70%. 
Prior to cloning individual sequences, the entire pool for each selection round that 
displayed activity was tested intermolecularly (in trans), where substrate molecules were 
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not covalently attached to pool sequences, although extensive Watson-Crick hydrogen-
bonding still allows strong interactions. Notably, a single-stranded DNA loop is formed 
when pool and substrate sequences are connected during selection rounds. Unfortunately, 
when the pools were tested intermolecularly, neither phosphorylation nor adenylylation of 
substrates was observed. This result indicated that none of the pools had sequences capable 
of supporting catalysis intermolecularly and the absence of the single-stranded loop 
explains this outcome. However, these results (especially for selections with the pool 
lacking an aptamer module) are in disagreement with previous reports of successful 
identification of deoxyribozymes with 5ʹ-phosphorylation as well as 5ʹ-adenylylation 
activities.9,10 This outcome means that DNA catalysts of DNA phosphorylation or 
adenylylation were inaccessible via the selection process as outlined here. In order to 
attempt to obtain DNA enzymes with these activities, the conditions of the selection step 
need to be changed. Instead, we set aside such efforts and focused on a different activity. 
 
4.2.2 In vitro selection of deoxyribozymes for phosphorylation of a 
tyrosine hydroxyl 
 Guided by recent discovery of tyrosine deoxyribozyme kinases in the Silverman 
laboratory38 and by an overall greater scientific interest in protein (rather than nucleic acid) 
modifications, we shifted our focus towards identification of modular deoxyribozymes 
capable of supporting amino acid phosphorylation. The recently reported tyrosine kinase 
deoxyribozymes emerged from selections in which GTP (guanosine triphosphate) was used 
as the phosphoryl donor. Upon further study of these DNA enzymes, ATP was also found 
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to support catalytic activity for one of them. The laboratory’s earlier report of 
deoxyribozymes for tyrosine dephosphorylation indicated additional competence of DNA 
to support catalysis involving a protein side chain and phosphoryl transfer.39 Having 
achieved tyrosine kinase reactivity (by nonmodular DNA catalysts) in the Silverman 
laboratory and possessing the knowledge and strategy for identifying such 
deoxyribozymes, we decided to evaluate our ability to find DNA kinases via the modular 
approach. We expected an improved access to catalysts via this approach, as described 
above. 
 
4.2.3 Tyrosine kinase selections with 1 mM ATP 
 Six DNA pools were synthesized with one of two ATP aptamers (DH and MB) 
adjacent to the N30, N40 and N50 DNA random regions (Table 4.1). Here, the aptamer 
sequences also served as primer-binding regions for PCR. Three additional pools lacking 
a predefined aptamer domain were prepared. Instead of the aptamer module, a 16-
nucleotide primer-binding sequence was located adjacent to the N30, N40 and N50 DNA 
random regions. The length of the random region was previously shown to be a critical 
experimental variable.40 Selection experiments with these nine pools were performed for 
tyrosine kinase activity towards a DNA-anchored CAAYAA hexapeptide substrate, which 
included a tyrosine acceptor of the phosphoryl group while ATP served as the phosphoryl 
donor. The hexapeptide was connected to the DNA anchor by a hexa(ethylene glycol), or 
HEG, tether (Fig. 4.3). 
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Name FD1 FE1 FF1 FG1 FH1 FJ1 FK1 FL1 FM1 
Random region  N30 N40 N50 N30 N40 N50 N30 N40 N50 
ATP aptamer no aptamer DH aptamer MB aptamer 
Table 4.1: Alphanumeric designation of each selection experiment with its corresponding 
DNA random region length and the ATP DNA aptamer (if any) integrated. For the FD1-FF1 
selections, a 16-nucleotide long fixed primer-binding region was used in place of an aptamer 
module for PCR amplification purposes. 
 
 
 The incubations during the key selection step were performed with 70 mM HEPES, 
pH 7.5, 1 mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2, 150 mM NaCl and 1 mM ATP at 
37 °C for 14 h. Because the Kd for the isolated DH ATP aptamer is on the order of 6 µM
11 
and the Kd for the isolated MB aptamer is in the similar range,
12 1 mM ATP concentration 
was expected to be fully saturating for each aptamer domain. 
Similar to the previous selection effort aimed at identification of polynucleotide 
kinases, here phosphorylation of a tyrosine side chain does not alone enable the selection 
process because phosphorylated substrate-pool conjugates cannot be readily separated 
from unreacted ones by PAGE. To enable the selection process, we exploited a previously 
identified deoxyribozyme, 8VP1, that is capable of attaching an RNA strand specifically 
to phosphorylated tyrosine, YP, within a peptide substrate while discriminating strongly 
against the unphosphorylated analogue, YOH (Fig. 4.4).41 This deoxyribozyme was used 
earlier to help identify nonmodular tyrosine kinase DNA catalysts.38 8VP1 provides ca. 25–
Figure 4.3: Structure of the DNA-anchored CAAYAA hexapeptide phosphorylation 
substrate. Note the hexa(ethylene glycol), or HEG, tether connecting the DNA 
oligonucleotide anchor (purple bar) to the peptide. 
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35% capture yield, which sets a corresponding upper limit on the observable yield from 
each random pool. In this work, 8VP1 is referred to as the “capture” deoxyribozyme 
because during the selection process it allows to capture (by PAGE shift) specific DNA 
sequences that phosphorylate tyrosine. 8VP1 plays the role of T4 DNA ligase used to 
capture catalytic sequences in the previous set of selection experiments. 
 
After iterating the selections for 14 rounds, only the FD (N30, no ATP aptamer 
module) and FG (N30, DH ATP aptamer module) selections displayed up to 14% and 9% 
catalytic activity, respectively. These yield values should be compared to the ca. 25–35% 
maximum capture yield by 8VP1, as indicated above. These yields were observed in rounds 
10 through 13 and individual sequences form each of the two pools at round 13 were cloned 
in and tested for activity. Although many clones were catalytically active, the highest 
phosphorylation yields were under 10%. Upon sequencing, all of the active 13FD1 clones 
Figure 4.4: Selection of nonmodular (A) and modular (B) tyrosine kinase deoxyribozymes. 
DNA-catalyzed peptide phosphorylation is followed by “capture” using the 
phosphotyrosine-specific 8VP1 deoxyribozyme and a 5ʹ-triphosphorylated RNA 
oligonucleotide, enabling PAGE-shift separation of kinase deoxyribozymes. The capture 
step is followed by PCR (not shown) to initiate the next selection round. 
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were found to be either single mutants or exactly identical to 8EA101, a nonmodular ATP-
dependent tyrosine kinase deoxyribozyme previously identified in the Silverman 
laboratory.38 Apparently, the 8EA101 sequence contaminated the FD1 selection, which 
was possible because the primer-binding sequences in both the EA1 and the FD1 selections 
were identical. This outcome was not surprising, noting previous instances of sequence 
contamination propagated by PCR. However, after cloning and sequencing of the 13FG1 
selection pool (N30, DH ATP aptamer module), one unique sequence, 13FG108, was 
identified. 
When prepared by solid-phase synthesis, the 13FG108 deoxyribozyme provided up 
to 30% tyrosine phosphorylation yield after 16 h. However, 13FG108 deoxyribozyme 
variant lacking the 27-nucleotide DH aptamer module catalyzed tyrosine phosphorylation 
with yields comparable to those for the full-length 13FG108. The dispensable nature of the 
aptamer module indicated that this domain provided no functional contribution to catalysis 
by 13FG108 DNA enzyme. Further evidence, based on mutational analysis, supported this 
conclusion. For this work, eight variants of the 13FG108 DNA catalyst with strategic 
single-nucleotide mutations in the aptamer sequence were synthesized. The study in which 
the DH ATP aptamer domain was initially identified also evaluated the importance of many 
individual nucleotides to ATP binding by the isolated aptamer.11 Five of the synthesized 
13FG108 variants included mutations that were shown to inhibit binding of ATP while 
three were known to be innocuous. When assayed with the hexapeptide substrate and ATP, 
three of the eight 13FG108 mutants (two innocuous and one deleterious) did not provide 
the expected outcome, therefore indicating no functional contribution of the aptamer 
module to catalysis. When a previously reported38 tyrosine kinase deoxyribozyme 
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identified via direct (nonmodular) selections was evaluated with various concentrations of 
NTPs (including ATP), strong inhibition of activity above 100 M ATP was observed. 
Although they were selected with 1 mM NTP, these DNA catalysts were inactive at this 
ATP concentration. Therefore, our inability to find truly modular deoxyribozymes for 
tyrosine phosphorylation in this particular selection effort was attributed to catalytic 
suppression induced by high concentration of ATP used in the selection process. 
 
4.2.4 Tyrosine kinase selections with 30 M ATP 
We hypothesized that tyrosine kinase deoxyribozymes with functional aptamer 
modules could still be found via selection experiments if the ATP concentration during the 
key incubation step was reduced. 30 M ATP (a 33-fold decrease from 1 mM ATP) was 
still expected to provide saturation of the ATP aptamer (Kd ~ 6 M) while avoiding 
catalytic suppression observed in earlier selection experiments. Similar to the previous 
efforts, but excluding the incorporation of the 37-nucleotide MB aptamer, six selections 
were initiated (Table 4.2). Importantly, to avoid contamination by earlier-identified DNA 
catalysts, primer binding regions for all pools were now substituted with sequences that 
were not used previously in any tyrosine kinase selection experiments. Incubations during 
the key selection step for all six pools were performed in the presence of 70 mM HEPES, 
pH 7.5, 1 mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2, 150 mM NaCl and 30 M ATP at 
37 °C for 14 h. 
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Name JN1 JP1 JQ1 JR1 JS1 JT1 
Random region  N30 N40 N50 N30 N40 N50 
ATP aptamer no aptamer DH aptamer 
Table 4.2: Alphanumeric designation of each selection experiment with its corresponding 
DNA random region length as well as presence or absence of the DH aptamer. For the 
JN1-JQ1 selections, a 16-nucleotide long fixed primer-binding region was used in place of 
the aptamer module. 
After 13 rounds, the N40 selection with the ATP aptamer module (JS1) showed 
0.9% yield, which rose to 3.1% at round 14 and 6.9% at round 17 (Fig. 4.5). All of these 
yield values should be compared to the 25–35% maximum capture yield by the 8VP1 
deoxyribozyme as indicated above. In contrast, none of the selections without the aptamer 
module (JN1-JQ1) as well as the N30 (JR1) and the N50 (JT1) selections with the integrated 
ATP binding region gave more than 0.7% yield through round 18. The round 14 N40 
modular pool (JS1) was cloned and sequenced, revealing that the population had converged 
on a single active sequence named 14JS101 (see Materials and Methods section for its 
nucleotide details). The intact ATP aptamer domain was necessarily present as part of the 
14JS101 sequence, as enforced by the method of selection (the forward PCR primer used 
to form the deoxyribozyme pool at the end of each selection round is the ATP aptamer 
sequence, Fig. 4.4). 
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 The 14JS101 deoxyribozyme provided up to 28% phosphorylation yield in 16 h 
when evaluated under the same incubation conditions as were used during the selection 
process, in a single-turnover assay with the DNA-anchored CAAYAA substrate provided 
separately from the deoxyribozyme. This assay directly monitored conversion of YOH to 
YP; no capture step was involved, as addition of a negatively charged phosphate increased 
electrophoretic mobility of the product relative to the unreacted substrate so the two 
corresponding PAGE bands could be reasonably well resolved and their intensities 
quantified. The identity of the DNA-anchored hexapeptide phosphorylation product was 
validated by MALDI mass spectrometry. The phosphorylation yield of 14JS101 at 24 h 
was optimized to 52–64% by incubation in 40 mM Tris, pH 7.5, 1 mM ZnCl2, 10 mM 
MnCl2, 40 mM MgCl2, 150 mM NaCl and 30 µM ATP at 37 °C. These optimized 
conditions were adopted for all further assays. The divalent metal ion dependence of 
14JS101 was assayed by omitting either one or two divalent metal ions that were present 
Figure 4.5: Progression of the JS1 selection experiment. The arrow marks the cloned round, 
number 14. Control reaction was performed in every selection round with the DNA-anchored 
hexapeptide with TyrP catalyzed by the 8VP1 deoxyribozyme. 
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during the selection process (Fig. 4.6A). Omitting either Mn2+ or Mg2+ led to a 36-fold and 
eight-fold decrease in yield, respectively, while Zn2+ was found to be strictly required for 
14JS101 catalysis. Additionally, Zn2+ concentration dependence of 14JS101 was also 
evaluated by performing reactions with a wide range of Zn2+ concentrations, from 0 mM 
to 4 mM (in 0.1 mM increments) as well as at 4.5 mM, 5.0 mM and 6.0 mM Zn2+ 
(Fig. 4.6B). The optimum yield for the reaction catalyzed by 14JS101 was achieved with 
1.0 mM Zn2+. 
 
Figure 4.6: Divalent metal ion dependence of the 14JS101 deoxyribozyme. (A) Ascertaining 
the requirements for inclusion of Zn2+, Mn2+ and Mg2+ (t = 30 s, 5 h, 24 h). (B) Determining 
the optimum Zn2+ concentration (yield values at 24 h are plotted). For all samples, the Tris 
concentration was held constant at 40 mM. Different symbols correspond to different data 
sets. The origin of the interesting and rather unusually shaped [Zn2+] dependence curve is 
unknown. 
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 One of the goals of this work was the identification of a truly modular 
deoxyribozyme, i.e., one in which an aptamer domain contributes functionally to its 
catalysis. To establish this for the 14JS101 DNA enzyme (as described for 13FG108 
analysis), we made use of the previously published information on the importance of 
individual nucleotides within the DH ATP aptamer to its binding of ATP.11 From those 
data, we chose five mutations anticipated to be deleterious for ATP binding and three 
mutations that should be innocuous, if the aptamer domain of 14JS101 contributes to 
catalysis by binding ATP (Table 4.3). Each of these eight mutations was made separately 
in 14JS101 and the kinase activity of each mutant was determined. An additional mutant 
of 14JS101 in which the entire 27-nucleotide aptamer domain sequence was scrambled was 
also examined (Fig. 4.7). For all but one mutant, the activity (or lack thereof) supported 
the conclusion that the ATP aptamer domain contributes directly to 14JS101 catalysis. For 
the A20C mutant, no activity was anticipated on the basis of the prior report, yet we 
observed substantial 14JS101 catalysis (~25% after 24 h). Noting that the A20G mutation 
of the same adenosine nucleotide is both expected and (here) observed to allow substantial 
activity, we surmise that the A20C mutation is simply not as deleterious in the 14JS101 
deoxyribozyme context as in the isolated ATP aptamer. Deleting or replacing the ATP 
aptamer module of 14JS101 with the 37-nucleotide MB aptamer that binds only a single 
molecule of ATP (versus two ATP molecules for the parent aptamer) resulted in no 
14JS101 activity under the same assay conditions (<0.5%, data not shown). 
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Parent  ACCTGGGGGAGTATTGCGGAGGAAGGT 
Innocuous 
mutants 
G8A ACCTGGGAGAGTATTGCGGAGGAAGGT 
G9A ACCTGGGGAAGTATTGCGGAGGAAGGT 
A20C ACCTGGGGGAGTATTGCGGCGGAAGGT 
G21A ACCTGGGGGAGTATTGCGGAAGAAGGT 
G22A ACCTGGGGGAGTATTGCGGAGAAAGGT 
Deleterious 
mutants 
G5A ACCTAGGGGAGTATTGCGGAGGAAGGT 
G7A ACCTGGAGGAGTATTGCGGAGGAAGGT 
A20G ACCTGGGGGAGTATTGCGGGGGAAGGT 
Scrambled  GTAGTTAGCGAGGCGTGACGAGGGTAG 
Table 4.3: List of the parent, eight single-mutant and one fully scrambled ATP aptamer 
sequences shown in the 5ʹ to 3ʹ direction. Mutated nucleotides are in boldface. The fully 
scramble aptamer sequence is italicized. Each aptamer variant at its 3ʹ-end is connected to 
the non-aptameric portion of 14JS101. Each variant 14JS101 sequence was synthesized 
separately. 
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 A first-order fit to the full kinetic plot of the parent 14S101 deoxyribozyme under 
optimized conditions produced a value for kobs (rate constant) of 0.21 h
–1. However, the 
curve fit heavily relies on yield values at later time points, when product formation is 
decelerating. To obtain more reliable values, initial-rate kinetics assays were performed. 
When these assays are done with varying ATP concentrations, the Michaelis constant, 
Km(ATP), for each active 14JS101 variant can be determined by plotting the calculated 
initial rate values against the corresponding concentrations of ATP. Then, each data set 
was fit to the following equation: 
Figure 4.7: Kinetic assays of the 14JS101 parent sequence and several mutants. For the gel 
image, t = 30 s, 5 h, 24 h (40 mM Tris, pH 7.5, 1 mM ZnCl2, 10 mM MnCl2, 40 mM MgCl2, 
150 mM NaCl and 30 µM ATP at 37 °C). In the plot, open symbols denote mutants expected 
to retain activity (innocuous mutations), and filled symbols denote mutants expected to lose 
activity (deleterious mutants). 
123 
 
𝑘obs = 𝑘cat ∙
𝐶𝑛
𝐾m
𝑛 + 𝐶𝑛
∙ (1 −
𝐶𝑚
𝐾i
𝑚 + 𝐶𝑚
) 
where kcat is the apparent kcat value (i.e., kobs at saturating ATP concentrations), C is the 
ATP concentration, Km is the apparent Km(ATP) value for productive ATP binding, Ki is 
the inhibition constant for unproductive ATP binding while n and m are Hill coefficients. 
The Km(ATP) of 14JS101 was determined to be ca. 10 µM (Fig. 4.8). This value is in 
accord with the 6 µM Kd value for the isolated ATP aptamer, consistent with direct 
contribution of the aptamer domain to 14JS101 catalysis. The Km(ATP) was also 
determined for each of the active mutants. In each case, the Km value was 11–32 µM, 
suggesting at most a minor perturbation in the ability to bind ATP. 
 
Figure 4.8: Assessment of Km(ATP) for the parent 14JS101 sequence and four mutants using 
initial-rate kinetics (0–2 h). Error bars (half of range) are shown for parent, G5A and A20G 
(each n = 2); some of the error bars are smaller than the sizes of the data points. For G7A 
and A20C, n = 1. Curve were fit using Hill coefficients of 2 for activation and 3 for inhibition. 
The fit Km(ATP) values are (top to bottom in legend, µM) 10.5 ± 1.2, 11.1 ± 1.2, 11.4 ± 1.6, 
22.2 ± 3.6 and 32.0 ± 5.3. 
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 The study in which the DH ATP aptamer domain was initially identified also 
evaluated its target specificity. In that report, none of the other three natural ribonucleotides 
were shown to bind the aptamer. In contrast, when ATP was substituted with dATP (which 
lacks the 2ʹ-OH of ATP), the DH aptamer successfully bound this variant of the target 
molecule. To further verify that the aptamer domain of 14JS101 is functionally responsible 
for binding ATP, the DNA catalyst was tested with GTP, CTP, UTP and dATP (Fig. 4.9). 
All of these nucleotides have structural similarities where triphosphate functional groups 
(which can donate the phosphoryl group from its -phosphate to phosphorylate tyrosine) 
are connected to pentose sugars with aromatic nucleobases. Notably, nonmodular tyrosine 
kinase deoxyribozymes were identified with GTP as the phosphoryl donor in the Silverman 
lab previously.38 When 14JS101 was tested with any of GTP, CTP or UTP, no activity was 
observed. However, dATP could successfully replace ATP. These findings are consistent 
with functional involvement of the DH ATP aptamer domain as intended. 
 
 
4.3 Summary 
 From these findings, we conclude that 14JS101 is a truly modular tyrosine kinase 
deoxyribozyme, in which the ATP aptamer domain binds the small-molecule ATP 
substrate while the separate, initially random (N40) region is responsible for catalysis. An 
Figure 4.9: Assays of the parent 14JS101 with all four 
standard NTPs and dATP. t = 30 s, 5 h and 24 h. 
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early ribozyme selection experiment attempted to include a predefined ATP aptamer 
domain to achieve polynucleotide kinase activity. However, the resulting aptamer domain 
became mutated during the selection process, and most of the corresponding ribozymes 
were unlikely to make functional use of the aptamer domain.42,43 Similarly, selection for a 
self-alkylating ribozyme using a biotinylated small-molecule substrate and a predefined 
biotin aptamer domain led to ribozymes that do not appear to use the (mutated) aptamer.44 
In contrast to these older results, the present work establishes unequivocally that nucleic 
acid enzymes can use discrete aptamer and catalyst domains that together enable catalytic 
function. The mechanistic basis for the collaborative operation of the aptamer and catalyst 
domains cannot be determined from the present data. Such insights likely require high-
resolution structure information, which is currently unavailable for any deoxyribozyme.45 
The DH aptamer used to identify 14JS101 binds two molecules of ATP. The available data 
do not establish conclusively whether or not 14JS101 requires binding of two ATP 
molecules. We speculate that if 14JS101 binds two ATP molecules, then only one of these 
molecules is properly oriented to serve as the phosphoryl donor. 
 A parallel goal of the present work was to evaluate whether including a predefined 
aptamer module leads to more robust identification of DNA catalysts. Although these 
experiments did successfully lead to 14JS101 as a single, explicitly modular kinase 
deoxyribozyme, a broader range of modular DNA catalysts was not found. Indeed, we 
found no deoxyribozymes at all from the analogous N30 and N50 modular selections as well 
as for all three N30, N40 and N50 selections without the integrated aptamer region. However, 
previous efforts in the Silverman laboratory with N30 and N50 random regions (but no 
aptamer domain) and using GTP as the phosphoryl donor did provide DNA catalysts.38 
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Moreover, the kobs of 0.2 h
–1 for 14JS101 is the same as the kobs of 0.2 h
–1 for the fastest 
NTP-dependent deoxyribozyme in the previous effort.38 Therefore, including a predefined 
aptamer module, while successful specifically for finding the 14JS101 deoxyribozyme, 
does not appear to be an especially helpful principle on which to design DNA catalyst 
selection strategies, at least for the kinase activity examined here. This conclusion is 
meaningful in the context of ongoing efforts to identify new deoxyribozymes that function 
with a wide range of small-molecule substrates. These findings establish experimentally 
that explicitly modular deoxyribozymes are possible, and for some purposes, pursuing such 
modularity may be advantageous. 
 
4.4 Materials and Methods 
4.4.1 Oligonucleotides, peptides and DNA-anchored peptide conjugates 
 DNA oligonucleotides were obtained from Integrated DNA Technologies 
(Coralville, IA) or prepared by solid-phase synthesis on an ABI 394 instrument using 
reagents from Glen Research (Sterling, VA). 5ʹ-Triphosphorylated RNA (pppRNA) 
oligonucleotides were prepared by in vitro transcription using synthetic DNA templates 
and T7 RNA polymerase. All oligonucleotides were purified by 7 M urea 8%, 12% or 20% 
(as appropriate) denaturing PAGE with running buffer 1× TBE (89 mM each Tris and boric 
acid and 2 mM EDTA, pH 8.3). 
 Peptides were prepared by solid-phase synthesis using Fmoc Rink amide MBHA 
resin, with N,N,N′,N′-tetramethyl-O-(7-azabenzotriazol-1-yl)uronium hexafluoro-
phosphate (HATU) as coupling agent. Each synthesis was performed at 0.2 mmol scale, 
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initiated using 308 mg of Rink amide resin with a loading capacity of 0.65 mmol/g 
(AAPPTec). All steps were monitored by ninhydrin test. For each coupling, 5 equivalents 
(1.0 mmol) of Fmoc-amino acid, 4.9 equivalents (373 mg, 0.98 mmol) of HATU and 10 
equivalents (350 µL, 2.0 mmol) of N,N-diisopropylethylamine (DIPEA) were mixed in 10 
mL of anhydrous DMF. The coupling reaction was initiated by adding this mixture to the 
resin and agitating by bubbling with nitrogen for 45 min, followed by washing with DMF 
(3 × 10 mL). The N-terminus of the newly installed amino acid was deprotected by 
agitating the resin in 20% piperidine in DMF (5 mL) under nitrogen for 5 min a total of 
three times, each time washing with DMF (3 × 5 mL). Peptides with N-terminal cysteine 
were capped via acetylation of their N-terminus by agitating the resin in 50 equivalents 
(924 µL, 10 mmol) of acetic anhydride and 25 equivalents of DIPEA (870 L, 5 mmol) in 
5 mL of DMF under nitrogen for 30 min. The peptide was cleaved from the solid support 
by stirring the resin in a separate vial with a solution containing 5 mL of trifluoroacetic 
acid (TFA), 125 µL of water, 125 µL of ethanedithiol and 50 L of triisopropylsilane for 
90 min. The liquid solution was separated from the resin by filtration. This solution was 
dried on a rotary evaporator to yield a solid. To this material 20 mL of cold diethyl ether 
was added, and the peptide was obtained as a white solid. 
 For the tyrosine kinase selections, the DNA anchor oligonucleotides were as 
follows: 
5ʹ-GGATAATACGACTCACTAT-HEG-p-C3-SS-C3-OH-3ʹ (FD1-FM1), 
5ʹ-GGACTATTGAAAGACATAT-HEG-p-C3-SS-C3-OH-3ʹ (JN1, JQ1, JS1), 
5ʹ-GGATCAGGTTACTAATTAT-HEG-p-C3-SS-C3-OH-3ʹ (JP1, JR1, JT1) 
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(see first structure in Figure 4.10), where the 3ʹ-disulfide linker was introduced via standard 
solid-phase DNA synthesis and unmasked to a 3ʹ-thiol by DTT treatment. A 50 µL sample 
containing 5 nmol of DNA anchor oligonucleotide in 100 mM HEPES, pH 7.5, and 50 mM 
DTT was incubated at 37 °C for 2 h. The reduced product was precipitated to remove 
excess DTT by addition of 50 µL of water, 10 µL of 3 M NaCl and 300 µL of ethanol. The 
precipitated product (DNA-HEG-p-C3-SH) was dissolved in 35 µL of water and 10 µL of 
100 mM triethylammonium acetate, pH 7.0. Activation as the pyridyl disulfide was 
achieved by adding 5 µL of 100 mM 2,2ʹ-dipyridyl disulfide in DMF and incubating at 
37 °C for 2 h. The product (DNA-HEG-p-C3-SSPy) was precipitated by addition of 50 µL 
of water, 10 µL of 3 M NaCl and 300 µL of ethanol and dissolved in 25 µL of water. 
Conjugation to the peptide was performed by adding 20 µL of 50 mM triethylammonium 
acetate, pH 7.0 and 5 µL of 20 mM peptide (100 nmol, 20 equivalents). The sample was 
incubated at 37 °C for 12 h, and the DNA-anchored peptide was purified by 20% PAGE. 
A typical yield was 3.5–4.5 nmol. 
 
Figure 4.10: Synthesis and structure of the DNA-anchored CAAYAA hexapeptide 
phosphorylation substrate. Note the hexa(ethylene glycol), or HEG, tether connecting the 
DNA oligonucleotide anchor to the peptide. 
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4.4.2 In vitro selection procedure 
 For the tyrosine kinase selections, the PCR step was performed as described in 
Chapter 2, except that Pfu polymerase was used in place of Taq polymerase because the 
former led to substantially greater yield of the desired PCR product. T4 DNA ligase was 
used to ligate each pool molecule to the DNA anchor. For the JN1, JQ1 and JS1 selections, 
the splint sequence for the ligation step in all rounds was 5ʹ-
ATATGTCTTTCAATAGTCCCCATCAGGATCAGCTCTATTGAAAGACATAT-3ʹ. 
Nucleotide details for the selection and capture steps of the JS1 selection are shown in 
Figure 4.11. For the other tyrosine kinase selections, the sequences to the 3ʹ-side of the 
pool’s random region (and of 8VP1 catalytic region) were complementary to the sequences 
of DNA anchors (shown in the previous section). Additionally, the sequence of the MB 
ATP aptamer used in the FK1-FM1 selections was 5ʹ-CCACTGAGGGGCGAGGAGAG-
AAACTGCGGGGAGTGG-3ʹ and the primer-binding sequences to the 5ʹ-side of the 
random regions were 5ʹ-CGAAGCGCTAGAACAT-3ʹ (FD1-FF1 selections), 5ʹ-CGAAA-
TGATGGCTATTTC-3ʹ (JN1 and JQ1 selections) and 5ʹ-CGAAATAGATTATCATTC-3ʹ 
(JP1 selection). While for the modular selections the aptamer was used to bind ATP, in the 
direct (nonmodular) selections, the left-hand DNA binding arm (i.e., the pool segment to 
the 5ʹ-side of the random region) could not interact with ATP and was also not base-paired 
to anything. The 8VP1 deoxyriozyme was validated to be highly selective for reaction of 
phosphorylated Tyr (TyrP) over unphosphorylated Tyr (TyrOH).41 The sequence of the 
8VP1 catalytic region was 5ʹ-GGACACGATGAGTGACTAAGTGGAATGAGGAAAG-
CACGAG-3ʹ. To avoid emergence of noncatalytic DNA sequences that migrate aberrantly 
at a fixed PAGE position, the length of the capture oligo reaction partner was alternated in 
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successive rounds between a short version (17 nt pppRNA, odd-numbered rounds 
including round 1) and a long version (54 nt pppRNA-DNA chimera, even-numbered 
rounds). The pppRNA-DNA chimera was prepared by splint ligation of the pppRNA 
component to the 5ʹ-phosphorylated DNA component using a complementary DNA splint 
and T4 DNA ligase. The short and long acceptor (capture) oligonucleotides had different 
sequences to avoid emergence of deoxyribozymes that catalyze unwanted covalent 
attachment of TyrOH to RNA during the capture step (this would be facilitated if the DNA 
random region had a sequence that allows substantial Watson-Crick base pairing to the 
constant capture oligo sequence). For the long capture oligo, the 8VP1 binding arm was 
extended several nucleotides past the RNA-DNA junction, which suppressed nonspecific 
cleavage by transesterification of the RNA nucleotides near the junction. 
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4.4.3 MALDI mass spectrometry of the 14JS101 phosphorylation product 
 The DNA-anchored CAAYPAA phosphorylation product was prepared from a 
10 µL sample containing 50 pmol of DNA-anchored HEG-tethered CAAYOHAA substrate 
(Fig. 4.12), 80 pmol of 14JS101 deoxyribozyme and 2 nmol of ATP, which were annealed 
in 5 mM Tris, pH 7.5, 15 mM NaCl and 0.1 mM EDTA by heating at 95 °C for 3 min and 
cooling on ice for 5 min. The DNA-catalyzed phosphorylation reaction was initiated by 
bringing the sample to 20 µL total volume containing 40 mM Tris, pH 7.5, 1.0 mM ZnCl2, 
10 mM MnCl2, 40 mM MgCl2 and 150 mM NaCl. The sample was incubated at 37 °C for 
Figure 4.11: Nucleotide details of the selection and capture steps of the JS1 selection (other 
modular tyrosine kinase selection experiments were performed analogously). (A) Selection 
step. (B) Capture step. 
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14 h, quenched with EDTA, desalted by Millipore C18 ZipTip and analyzed by MALDI 
mass spectrometry (Bruker UltrafleXtreme; matrix 3-hydroxypicolinic acid, positive ion 
mode). 
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